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 1 
SUMMARY 
Background: RPE65, a pigment epithelial protein, is essential for the 
regeneration of 11-cis retinal - the chromophore of both cone and rod visual pigments. 
Mutations in Rpe65 lead to a spectrum of retinal dystrophies ranging from congenital 
blindness to autosomal recessive Retinitis Pigmentosa (RP). More than 80 disease-
associated mutations have been identified in the Rpe65 gene. According to in vitro 
studies, many of these pathogenic mutations appear to result in a partial or a complete 
loss of RPE65 function. The most frequent mutation found in patients is an amino acid 
substitution at position 91 (R91W). Patients carrying this mutation have useful cone-
mediated vision in the first decade of life suggesting that the mutant RPE65 protein is 
still functional. All currently available animal models for RPE65-caused visual defects 
are functional knock-outs. Therefore, these models cannot reproduce the previously 
described human pathology caused by missense mutation. I generated an R91W 
knock-in mouse as a model to understand the mechanism of retinal degeneration 
caused by aberrant Rpe65 function.  
Results: the R91W mutation caused a reduction of RPE65 protein expression. As 
a consequence, reduced amounts of 11-cis retinal and disturbed rhodopsin 
regeneration kinetics were detected. The insufficient supply of the 11-cis retinal to the 
photoreceptors resulted in retinal degeneration as evidenced by: disturbed 
photoreceptor morphology, progressive loss of photoreceptor nuclei paralleled by an 
increase in retinal degeneration markers, and accumulation of abnormal inclusions in 
the retinal pigment epithelium. Accordingly, electrophysiological measurements 
showed severely affected photoreceptor responses. After selective ablation of rod 
activity functional tests revealed that the cone function is preserved at earlier ages in 
R91W knock-in mice.  
The phenotype of R91W knock-in mice was clearly distinctive from that of Rpe65 
deficient mouse evidenced by: i) presence of reduced but detectable mutant RPE65 
protein ii) presence of 11-cis retinal and rhodopsin, and their temporal persistence 
even in the old animals, iii) better preservation of retinal morphology at least at earlier 
ages iv) prolonged survival of cones, v) and preserved cone function, which is lost 
early postnatally in Rpe65-/-. 
Significance: The R91W knock-in mouse mimics many aspects of the human 
pathology and thus is a more appropriate model for pre-clinical investigations than the 
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Rpe65 knock-out mouse. Particularly, the relative longevity of cones in R91W knock-in 
mice may have dramatic impact on upcoming clinical trials with regard to the 
therapeutic window in the corresponding patients. 
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ZUSAMMENFASSUNG 
Hintergrund: RPE65 ist ein Protein des retinalen Pigmentepithels, welches das 
Chromophor für die Stäbchen und Zapfen Sehpigment – Apoproteine generiert. 
Mutationen im Rpe65 Gen führen zu Netzhautdystrophien mit einer Bandbreite von 
autosomal rezessiver Retinitis Pigmentosa (RP) bis hin zu Blindheit bei der Geburt. 
Mehr als 80 Mutationen im Rpe65 Gen führen zur Erkrankung. In vitro Studien deuten 
darauf hin, dass viele dieser Mutationen zu einem teilweisen oder sogar vollständigen 
Funktionsverlust führen. Die in Patienten am häufigsten gefundene Mutation in Rpe65 
führt zu einer Aminosäuresubstitution an Position 91: R91W. Patienten mit dieser 
Mutation haben brauchbares Zapfensehen während der ersten Lebensdekade, was 
darauf hindeutet, dass das mutierte RPE65 eine Restfunktion hat. Alle zur Zeit 
verfügbaren Tiermodelle sind hingegen echte (funktionelle) knock-outs, d.h. sie sind 
keine geeigneten Modelle für Erkrankungen, die durch eine Missense Mutation wie 
R91W verursacht werden. Ich habe im Rahmen dieser Arbeit eine R91W knock-in 
Maus hergestellt, um den Mechanismus der Degeneration bei ungenügender RPE65 
Funktion zu untersuchen. 
Ergebnisse: Die R91W Mutation führt zu einer Reduktion der RPE65 Protein 
Expression. Daraus resultiert ein reduzierter 11-cis Retinal Gehalt und eine gestörte 
Kinetik der Rhodopsin Regeneration. Die Unterversorgung mit 11-cis Retinal führt zur 
Degeneration der Netzhaut, was durch folgende Befunde deutlich wird: Gestörte 
Morphologie der Photorezeptoren, zunehmender Verlust von Photorezeptoren mit 
einem Anstieg von Degenerationsmarkern und schliesslich eine Zunahme abnormaler 
Einschlüsse im Pigmentepithel. In Übereinstimmung mit diesen Befunden zeigt sich, 
dass die Funktion der Photorezeptoren deutlich eingeschränkt ist. Selektive Inhibition 
der Stäbchenfunktion führte darüberhinaus zu der Erkenntnis, dass die Funktion der 
Zapfen zumindest in jungen R91W knock-in Tieren erhalten ist. 
Dieser Phänotyp unterscheidet sich deutlich von dem der Rpe65 knock-out 
Maus, wie folgende Parameter belegen: 1) RPE65 Protein ist in der knock-in Maus 
detektierbar 2) 11-cis Retinal und Rhodopsin sind auch in älteren knock-in Tieren 
messbar 3) Die Netzhautmorphologie ist zumindest in jüngeren knock-in Tieren besser 
erhalten 4) Zapfen bleiben länger erhalten 5) Zapfenfunktion ist in der knock-in Maus 
messbar, geht in der knock-out Maus hingegen früh nach der Geburt verloren. 
ZUSAMMENFASSUNG 4 
Signifikanz: Die R91W knock-in Maus weist viele Eigenschaften der 
menschlichen Erkrankung auf, und ist daher als Modell für prä-klinische Studien besser 
geeignet als die Rpe65 knock-out Maus. Insbesondere die Langlebigkeit der Zapfen in 
der knock-in Maus könnte einen dramatischen Einfluss auf die anstehenden klinischen 
Versuche haben, vor allem in Bezug auf das therapeutische Fenster in den 
entsprechenden Patienten. 
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1 INTRODUCTION 
 
1.1 Principle organization of the retina 
 
The retina is organized in different layers, which contain very specific cell types 
(Figure 1). Light enters the eye from the anterior segment and first passes the ganglion 
cell layer (GCL). Ganglion cells are the tertiary neurons of the retina that collect all 
input from secondary neurons, integrate the signal and transmit it to higher visual 
centers along the optic nerve. Connections to secondary neurons are made within the 
inner plexiform layer (IPL). There are three principal neuronal cell types present in the 
inner nuclear layer (INL): Bipolar cells receive input from photoreceptors and propagate 
the signal to ganglion cells. The output of bipolar cells onto ganglion cells may be 
modulated by amacrine cells within the IPL. The input to bipolar cells may be 
modulated by horizontal cells at the level of the outer plexiform layer (OPL). Bipolar 
cells and photoreceptors have synaptic contact in the OPL. The outer nuclear layer 
(ONL) comprises photoreceptor nuclei. Light that has passed all layers described so 
far, finally reaches the outer segments (OS) of photoreceptors, which contains the 
light-sensitive visual pigment. Two principal types of photoreceptors – rods and cones 
– are responsible for dim light vision or color vision, respectively. Behind the 
photoreceptors follows the retinal pigment epithelium (RPE), which has several 
functions essential for photoreceptor function and maintenance. RPE and 
photoreceptors depend on the blood supply provided by the choroid. The other retinal 
layers are supported by vessels within the retina (not depicted). Müller cells span 
almost all layers of the retina and have several functions in ionic homeostasis, 
clearance of neurotransmitters and maintenance of retinal integrity (Figure 1).  
The direct route of visual transmission: photoreceptors – bipolar cells – ganglion 
cells is modulated by lateral interactions of horizontal and amacrine cells. The major 
focus of this thesis is however placed on two cell types in the retina: the RPE and 
photoreceptors; which will be discussed in further parts.  
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Figure 1 Retinal organization  
The retina consists of two principle structures, the neural retina 
and the retinal pigment epithelium (RPE). The neural retina is 
arranged in 3 cell layers: i), outer nuclear layer (ONL), containing 
nuclei of photoreceptors, ii) inner nuclear layer (INL), containing 
secondary and inter- neurons and iii) the ganglion cell layer (GCL), 
projecting to the brain. The nuclear layers consist of cell bodies of 
five basic neuronal cell types: photoreceptors (ONL); bipolar, 
horizontal and amacrine cells (INL) and ganglion cells (GCL). The 
processes and synaptic contacts are located in the inner plexiform 
layer (IPL) and outer plexiform layer (OPL), respectively. Müller 
cells are the radial glial cells of the retina. The outer limiting 
membrane (OLM) of retina is formed from adherens junctions 
between Müller cells and photoreceptor cell inner segments.  
IS, inner segments; OS, outer segments of photorecptors.  
 
 
1.1.1 Photoreceptors  
 
Photoreceptors in the retina are light sensitive cells that convert light into a 
neuronal signal. The human retina contains two types of photoreceptors, rods and 
cones. The rods outnumber the cones, 110–125 million vs. 6 million, respectively 
(Osterberg 1935). The distribution of rods and cones throughout the human retina 
varies from periphery to the center, in contrast to non-primate species. The macula, the 
central portion of the retina, is characterized by a high density of photoreceptors. In its 
center is the fovea, an area containing exclusively cone photoreceptors. Approximately 
200’000 cones are found in the fovea. This cone-rich area is responsible for clear and 
sharp central color vision. 
The basic anatomy of rods and cones is shown schematically in Figure 2. Both 
photoreceptor types consist of a cell body with the synaptic terminus on one side and 
the inner segment containing the metabolic machinery of the cell (the mitochondria, 
Golgi apparatus, endoplasmic reticulum etc.) on the opposite side. The outer segment 
of rods, which extends from the inner segment, contains a stack of about 1000 
membrane discs, containing the photopigment rhodopsin (Figure 2) (Forrester et al. 
1996). Cones have no disks; instead surface enlargement is achieved by infoldings of 
the plasma membrane. Cones possess less photopigments per cell than rods.  
Each photoreceptor cell has a single type of photopigment composed of a protein 
opsin (rod-, cone- and color-specific) to which the chromophore 11-cis retinal is 
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covalently bound. Rods express only one type of opsin and their photopigment 
rhodopsin has a maximal spectral sensitivity at 496 nm (Dartnall et al. 1983). Three 
kinds of cone pigments are expressed in human retinas: red- (long, 558 nm), green- 
(middle, 531 nm) and blue-sensitive pigment (short, 419 nm) representing maximal 
sensitivity to red, green or blue light, respectively (Dartnall et al. 1983). Rod 
photoreceptors are highly sensitive to light of low intensity and therefore the rod system 
is optimized for sensitivity at the expense of resolution. Cones, however, function 
predominantly in bright light where they are involved in detecting color. The cone 
system, especially in the fovea, provides high spatial resolution and is specialized for 
acuity at the expense of sensitivity. In extreme illumination conditions (dim light as 
opposed to bright light) basically two types of photoreceptor responses exist: i) under 
conditions of low luminance exclusively rods are sufficiently sensitive to respond. This 
rod-mediated perception is called scotopic vision. ii) Conversely under bright light 
conditions, responses of rods are saturated, and only cones contribute to vision. This 
type of vision is termed photopic vision. In intermediate lighting conditions a mixed 
response occurs. This type of vision is called mesopic vision. Functionally, these 
properties of photoreceptors can be tested by electroretinography (ERG), which 
measures the light-evoked electrical responses of various cell types in the retina in 
addition to the photoreceptors.  
 
Figure 2 Photoreceptor structural organization 
Rods and cones share many structural features and both 
are extremely polarized cells. Both have synaptic 
terminals connected to the soma located within the ONL. 
The lumen of the soma is almost entirely occupied by the 
nucleus. Endoplasmic reticulum and mitochondria are 
displaced into the inner segment. Any protein 
synthesized here has to be transported through the 
connecting cilium to reach the outer segment. In the case 
of rods, the outer segments contain densely packed 
discs, which increase the area for high-density packing of 
the visual pigment in an orientation allowing maximal 
photon catch. In cones, OS membranes are not 
organized as separate disks but are continuous, 
invaginating from the plasma membrane. The tip of each 
photoreceptor is surrounded by RPE-villous processes to 
enable the efficient exchange of nutrients, vitamin A and 
photoreceptor renewal. 
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1.1.2 Retinal pigment epithelium (RPE) 
 
The RPE, located immediately behind the photoreceptors, is a single layer of 
cells, which was termed pigmented due to its large content of melanin pigment. This 
pigmentation influences vision physically by eliminating light scattering. 
The RPE is involved in many aspects of outer retinal metabolism that are 
essential for the continued maintenance of the photoreceptor cells such as: protection 
against photo-oxidation, transport of nutrients between photoreceptors and the 
choriocapillaris, buffering of ions in the subretinal space, secretion of trophic factors 
etc. The apical side of the RPE cells with their microvilli surrounds the tips of 
photoreceptor cells (Figure 1 and 2), creating a large surface for exchange between 
the two cell types. Probably the two most important features of the RPE are 
phagocytosis of shed photoreceptor tips and regeneration of the visual pigment 
chromophore. Photoreceptor exposure to intense light levels leads to accumulation of 
high concentration of radicals, photo-damaged proteins and lipids in the tips of their 
outer segments. These tips are shed diurnally and phagocytosed by the RPE. In turn, 
the outer segments are renewed on their basal side, at the connecting cilium (Figure 
2). It is estimated that the turnover rate - the time needed to form an entirely new 
photoreceptor outer segment - in the primate retina takes about 10 days (Young 1971). 
The shed tips are digested in the RPE and critical molecules are recycled and returned 
back to the photoreceptors. With age this complex process appears to slow down, 
possibly contributing to blinding diseases such as age-related macular degeneration 
(AMD). 
Regeneration of the visual pigment chromophore, another kind of recycling in the 
RPE, will be discussed in the following section.  
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1.2 Light-induced biochemical responses of the retina 
 
The visual pigment in rod cells, rhodopsin, consists of the transmembrane protein 
opsin covalently bound to the chromophore 11-cis retinal. Opsin has seven membrane-
spanning helices, similar to other receptors that interact with transducing G proteins. 
Rhodopsin is localized to the flattened membrane disks that are piled in the rod’s outer 
segment (Figure 2). 
In the resting state, cyclic-nucleotide-gated channels (CNG) in rod plasma 
membrane are open, allowing the simultaneous inward flux of Na+, Ca2+, and K+ ions 
(Figure 3). As a result the membrane potential of a resting rod cell is about -37 mV 
(Schneeweis and Schnapf 1995), which is considerably lower than the resting potential 
typical of neurons (-60 to -90 mV). Due to this constant depolarization, dark-adapted 
rod cells are constantly secreting the neurotransmitter glutamate. Depending on the 
type of the downstream bipolar cell, the glutamate stimulates the OFF-pathway or 
inhibits the ON-pathway, respectively. With no excitatory neurotransmitter release from 
bipolar cells, ganglion cells are also turned off.  
When a photon of light reaches the photoreceptor outer segment a series of 
molecular events culminating in an electrical response is induced. The primary 
photochemical event is isomerization of the 11-cis retinal in rhodopsin to all-trans 
retinal. In the following text two separate processes induced by light are described.  
 
1.2.1 Phototransduction  
 
Phototransduction is the process by which the energy of a photon of light is 
converted in the photoreceptor cell outer segment into a neuronal signal e.g. a change 
of a transmembrane potential (reviewed in (Burns and Baylor 2001; Arshavsky et al. 
2002)). Light absorption leads to the photoisomerization of 11-cis retinal to all-trans 
retinal causing a physical change in the opsin moiety of rhodopsin leading to a 
conformational state called metarhodopsin II. Metarhodopsin II activates the 
photoreceptor-specific G protein, transducin. Transducin is a heterotrimeric protein that 
in its inactive state is composed of α, β and γ subunits (Figure 3). Metarhodopsin II 
activation results in the fast exchange of GDP for GTP on the α subunit of transducin 
causing release of the β and the γ subunit. The GTP bound α subunit of transducin 
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causes activation of a phosphodiesterase (PDE) (Figure 3). The PDE is a 
heterotetramer composed of two catalytical subunits and two identical regulatory 
subunits (PDEγ). The role of the PDEγ subunit is to maintain the PDE in a nonactivated 
state. The activated α subunit of transducin binds to the PDEγ subunit resulting in the 
activation of the two catalytic subunits of PDE. Its activation results in the degradation 
cGMP to GMP (Figure 3). The decrease in cGMP concentration leads to the closure of 
the CNG channels. The closure of the CNG channels results in a decrease in cation 
influx and as the export of Ca2+ continues for additional 1 sec, this causes a 
hyperpolarization of the cell (Figure 3). This complex biochemical cascade initiated by 
photon capture provides enormous signal amplification. It has been estimated that the 
absorption of a single photon by a rhodopsin molecule causes a net change in the 
membrane potential of about 1 mV (Schneeweis and Schnapf 1995). The amplification-
factor is about 1 million and makes photoreceptors the ultimate sensory neurons as 
they are able to detect and respond to a single photon (Baylor et al. 1979) 
Accompanying the light induced hyperpolarization, decreased influx together with 
continuous export of Ca2+ lowers the intracellular Ca2+ concentration, leading to 
adaptational changes in the phototransduction cascade, all of which tend to reduce the 
sensitivity of the receptor to light. The combination of these adaptive mechanisms 
allows the retina to function at light intensities differing by 10 log units (reviewed in 
(Reme et al. 1991)). 
In order to quickly restore the system’s basal state all the activated intermediates 
(metarhodopsin II, α subunit of transducin and activated PDE) need to be inactivated 
rapidly. Lowered intracellular Ca2+ concentration disinhibits guanylate-cyclase-
activating protein (GCAP), leading to the activation of guanylate cyclase (GC) and thus 
resynthesis of cGMP. PDE is inactivated by the hydrolysis of the GTP bound to the α 
subunit of transducin allowing re-formation of the transducin trimer and release of PDE. 
Rhodopsin is phosphorylated by rhodopsin kinase (RK) and inactivated by binding of 
arrestin. The protein arrestin blocks the ability of activated rhodopsin to interact with 
transducin, and also facilitates the release of all-trans retinal (the opsin agonist) from 
the opsin. The released all-trans retinal then enters an elaborate recycling system: the 
visual cycle.  
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Figure 3 A schematic representation of the phototransduction cascade in the rod outer segments 
of vertebrates.  
Phototransduction in rod photoreceptors starts with the absorption of a photon by the visual pigment 
rhodopsin, which sits in the membrane of the disc. The absorption triggers a conformational change first in 
the chromophore (11-cis to all-trans) and subsequently in the protein moiety, the opsin. This change allows 
the binding of transducin, which now exchanges GDP for GTP and sheds its two inhibitory subunits 
gamma and beta. Activated transducin triggers activation of PDE, which starts hydrolyzing cGMP and thus 
quickly removes the ligand of the CNG channel at the cell surface. Upon channel closure, the membrane 
potential of the photoreceptor hyperpolarizes – a light signal has been converted into an electrical signal 
that is interpretable by neurons. Following cessation of the stimulus, cGMP levels are restored by the 
activity of GC, which below a certain level of free Ca2+ becomes activated by GCAPs. The transduction 
cascade is amplified by about 1 million times and can be modulated at several levels. 
cGMP, cyclic GMP; CNG, cyclic nucleotide gated; GC, guanylate cyclase; GCAP, guanylate-cyclase-
activating protein; GDP, guanosine diphosphate; GMP, guanosine monophosphate; GTP, guanosine 
triphosphate, PDE, phosphodiesterase.  
Taken from (Kramer and Molokanova 2001) 
 
1.2.2 The visual cycle for retinoid regeneration 
 
Photoisomerisation (bleaching of rhodopsin) of 11-cis retinal to all-trans retinal 
causes the dissociation of all-trans retinal from the opsin molecule. The restoration of 
light sensitivity of the bleached opsin requires regeneration of 11-cis retinal through an 
enzymatic pathway called the visual cycle. Several enzymatic steps are required to 
convert all-trans retinal to 11-cis retinal and the biochemical reactions that carry out the 
trans to cis conversion are confined to the RPE (Redmond et al. 1998) (Figure 4). After 
photon absorption and release from the opsin molecule, all-trans retinal is transported 
out of rod disc membrane by a retina-specific ATP-binding cassette protein (ABCR) to 
the cytoplasm. All-trans retinol dehydrogenase (atRDH) reduces the aldehyde to all-
trans retinol. All-trans retinol is then released from the outer segments of the 
INTRODUCTION 14 
photoreceptor cells, bound to the inter-photoreceptor retinol binding protein (IRBP) and 
carried into the RPE. Once inside the RPE, all-trans retinol is bound to cellular retinol 
binding protein (CRBP) (Saari et al. 1982) (Figure 4). A transferase enzyme, lecithin 
retinol acyl transferase (LRAT), esterifies the all-trans retinol to produce all-trans retinyl 
ester (Saari and Bredberg 1989; Trehan et al. 1990). This ester form is the substrate 
for RPE65 that acts as an isomerohydrolase (IMH) catalyzing the hydrolysis of all-trans 
retinol and subsequent isomerization into 11-cis retinol (Jin et al. 2005; Moiseyev et al. 
2005; Redmond et al. 2005). 11-cis retinol dehydrogenase (11cRDH) then oxidizes 11-
cis retinol to 11-cis retinal (Simon et al. 1995) in a reaction accelerated by the presence 
of cellular retinaldehyde binding protein (CRALBP) (Saari et al. 2001).  
Finally, 11-cis retinal is transported back to the photoreceptor and the opsin 
molecule. During the regeneration process, the derivatives of retinol (retinoids) are 
bound by retinoid-binding proteins (IRBP, CRBP, CRALBP) to solubilize the 
hydrophobic retinoids and to protect them from oxidation.  
After it is transported back into the outer segment, the 11-cis retinal recombines 
with opsin in the receptor disks (Figure 4).  
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Figure 4 The visual cycle  
Upon photon absorption 11-cis retinal is converted into all-trans retinal and released into the disc lumen. 
The transport across the disc membrane is facilitated by ABCR and the aldehyde is reduced into all-trans 
retinol by an atRDH. All-trans retinol leaves the photoreceptor by so far unknown mechanisms and is 
chaperoned by IRBP in the extracellular space. It enters the RPE – again by unknown mechanisms – in 
the lumen of which it is chaperoned and transported by CRBP. All-trans retinol is esterified to a fatty acid 
by LRAT. The resulting all-trans retinyl ester is the storage form for vitamin A in the eye and the substrate 
for RPE65 hydrolysing the all-trans retinol from the ester and inducing the re-isomerization to 11-cis 
retinol. 11-cis retinol binds to CRALBP and in a subsequent step is oxidized by a 11cRDH to form 11-cis 
retinal. Alternatively, 11-cis retinol may be esterified by LRAT to yield 11-cis retinyl esters, a storage form 
of pre-isomerized retinoid. 11-cis retinyl esters are hydrolyzed to 11-cis retinal by 11cREH, which is not yet 
cloned. 11-cis retinal leaves the RPE, is chaperoned by IRBP during its transport back to the 
photoreceptor and - by unknown mechanisms – reaches the naked opsin to restore its light-sensitivity. 
11cRDH, 11-cis retinol dehydrogenase; 11cREH, 11-cis retinyl ester hydrolase; ABCR, ATP-binding 
cassette retina; atRDH; all-trans retinol dehydrogenase; CRALBP, cellular retinaldehyde binding protein; 
CRBP, cellular retinol binding protein; IRBP, inter-photoreceptor retinol binding protein; LRAT, lecithin 
retinol acyl transferase; RPE, retinal pigment epithelium 
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1.3 Human retinal dystrophies and degenerations 
 
Retinal dystrophies and degenerations can be caused by genetic or non-genetic 
factors, and typically affect specific cell types within the retina.  
Age-related macular degeneration (AMD) is a degenerative retinal disease 
specifically affecting the macula of elderly people. The macula is the central, cone-rich 
region of the retina that is responsible for clear and sharp central vision. As a general 
rule, AMD is causing severe visual impairment characterized by poor visual acuity and 
impaired color vision. AMD is a major leading cause of blindness in the aged 
population over 60. AMD is a multifactorial disorder that is associated with 
environmental risk factors such as cigarette smoking, nutrition, life-long exposure to 
light, and cholesterol level. However, it has been recently established that genetic 
factors also contribute to pathogenesis of AMD. Independent studies suggested that 
missense mutations in complement factor H (CFH) may lead to AMD with a prevalence 
close to one half of all AMD disease cases (Conley et al. 2005; Edwards et al. 2005; 
Hageman et al. 2005; Haines et al. 2005; Klein et al. 2005; Zareparsi et al. 2005). 
Another study showed that variation in factor B (BF) and complement component 2 
(C2) genes may be additional risk loci for AMD (Gold et al. 2006). Collectively, these 
data point to a causative role of the immune system in the development of AMD. In 
addition, the PLEKHA1/LOC387715 locus within 10q26 has been described as a 
possible second major locus contributing to AMD development (Jakobsdottir et al. 
2005; Rivera et al. 2005). 
Retinal dystrophies are a genetically and phenotypically diverse group of 
inherited diseases that lead to visual impairment, affecting all age groups and ethnic 
backgrounds. Based upon clinical symptoms, ERG, and/or genetical similarities a 
common grouping has been made to classify retinal diseases. I.e. retinitis pigmentosa 
(RP) is a collection of progressive inherited disorders in which abnormalities of the 
photoreceptors (rods and cones) or the RPE lead to progressive visual loss. The mode 
of inheritance in RP may be autosomal dominant, autosomal recessive, X-linked, or 
mitochondrial. RP is characterized by initial loss of rods, resulting in night blindness, 
constricted visual fields, and fundus alterations. While AMD, primarily affecting the 
macula, rarely results in complete blindness, hereditary retinal degenerations that 
affect the whole retina tend to be more severe. More than 170 gene loci have been 
associated with retinal dystrophies  (http://www.sph.uth.tmc.edu/Retnet/disease.htm). 
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Most of these genes are specifically expressed in the retina, particularly in 
photoreceptors. 
 
1.3.1 Genes associated with inherited retinal degenerations affecting 
photoreceptor function 
Retinal dystrophies, which include RP, form one of the largest single cause of 
inherited blindness in the developed world. RP affects about 1 in 3500 people 
worldwide. Mutations in rhodopsin gene are the most common cause of RP. The P23H 
mutation in rhodopsin was the first gene mutation shown to cause RP, accounting for 
12% of the adRP population in the US (Dryja et al. 1990; Sung et al. 1991). Mutations 
in the rhodopsin gene can lead to adRP, arRP or congenital stationary night blindness 
(CSNB) (illustrated in Figure 5). This phenotypic divergence is called allelic 
heterogeneity. On the other hand mutations in different genes can lead to similar 
phenotype; i.e. CSNB can result from mutations in rhodopsin, transducin, arrestin etc.  
Most genes associated with RP encode proteins involved in phototransduction, the 
visual cycle, photoreceptor structure and transcription factors. 
 
 
Figure 5 A brief overview of photoreceptor-related proteins linked to various types of retinal 
diseases 
Several examples of genes involved in the phototransduction cascade, photoreceptor structure, 
metabolism or morphogenesis and their connection to disease. 
ADRP, autosomal dominant RP; ARRP, autosomal recessive RP; CD, cone dystrophy; CRD, cone-rod 
dystrophy; CSNB, congenital stationary night blindness; LCA1, Leber congenital amaurosis type 1; MD, 
macular degeneration; RP, retinitis pigmentosa; Stgdt, Stargardt; XLRS, X-linked retinoschisis. 
Adapted from http://www.biochem.ubc.ca/fac_research/faculty/molday.html 
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1.3.2 Inherited retinal degenerations caused by mutations in genes of the visual 
cycle and animal models 
 
Sustained visual function depends on a functional visual cycle replenishing the 
vitamin A derivative - 11-cis retinal - to the opsin molecule. Defects in Vitamin A 
metabolism in the RPE may result in dysfunction and degeneration of the retina.  
 
Table 1 Visual cycle genes in conjunction with human eye diseases and animal models  
Enzyme/ protein Abbrev. Gene Human disease(OMIM; RetNet) Mouse model 
All-trans retinol 
dehydrogenase atRDH 
RDH8 
(prRDH) no KO (Maeda et al. 2005) 
ATP-binding 
cassette retina ABCR ABCA4 
Stargardt disease, arMD; arRP; ar 
fundus flavimaculatus; ar cone-rod 
dystrophy; 
KO (Weng et al. 1999) 
Inter-photoreceptor 
retinol binding 
protein 
IRBP RBP3 no KO (Liou et al. 1998) 
Cellular retinol 
binding protein CRBP RBP1 no 
KO (Ghyselinck et al. 
1999) 
Lecithin retinol acyl 
transferase LRAT LRAT LCA, EOSRD 
KO (Batten et al. 2004) 
(Liu and Gudas 2005) 
RPE65 RPE65 RPE65 LCA, arRP, EOSRD 
KO (Redmond et al. 
1998), rd12 (Pang et al. 
2005), Briard dog 
(Aguirre et al. 1998) 
11-cis retinol 
dehydrogenase 11cRDH RDH5 
ar fundus albipunctatus; ar cone 
dystrophy, 
KO (Driessen et al. 
2000) 
Cellular 
retinaldehyde 
binding protein 
CRALBP RLBP1 
ar RP, ar retinitis punctata 
albescence, ar Bothnia dystrophy, ar 
cone-rod dystrophy 
KO (Saari et al. 2001) 
Retinal G-protein-
coupled receptor RGR RGR arRP, adRP KO (Chen et al. 2001) 
ad, autosomal dominant; ar, autosomal recessive; EOSRD, early-onset severe retinal dystrophy; LCA, 
Leber congenital amaurosis; MD, macular degeneration; RP, retinitis pigmentosa; KO, Knock-out 
(http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM; http://www.sph.uth.tmc.edu/Retnet/disease.htm)  
 
Genetic models developed to study visual cycle genes revealed that defects in 
RPE-specific genes might result in photoreceptor cell loss as a primary event, and vice 
versa. I.e. defects in genes expressed in the RPE – such as Rpe65 and MerTK (c-mer 
proto-oncogene tyrosine kinase) – primarily result in photoreceptor degeneration. On 
the other hand, a defect in a gene exclusively expressed in photoreceptors – ABCR - 
leads to RPE degeneration. Such close interdependence between photoreceptors and 
RPE led to the consideration of RPE and photoreceptors as a one functional unit. The 
metabolic processes in the RPE are very complex, and many of the proteins involved 
in the visual cycle are not identified or fully characterized. Table 1 shows proteins of 
established function in the visual cycle in connection to human disease and developed 
animal models. Patients with mutations in atRDH (RDH8), IRBP (RBP3) and CRBP 
(RBP1) have not been reported so far. 
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1.4 The Rpe65 gene: retinoid regeneration and retinal 
degeneration 
 
Nicoletti et al. characterized the human Rpe65 gene and mapped it to 
chromosome 1 (Nicoletti et al. 1995). The Rpe65 gene consists of 14 exons spread 
over 20 kilobase pairs encoding the abundant 61-kDa protein of the retinal pigment 
epithelium (Hamel et al. 1993b). This protein constitutes up to 50% of the total 
microsomal protein amount in the RPE cells (Hamel et al. 1993a). Protein sequence 
comparison revealed high evolutionary conservation of RPE65 with mouse and human 
protein being 94% identitical.  
Together with recently crystallized apocarotenoid-15,15-oxygenase (ACO) from 
Synechocystis sp., RPE65 belongs to a family of retinal-forming carotenoid 
oxygenases (Kloer et al. 2005). As in ACO, four conserved histidines coordinating an 
iron atom are required for its catalytic activity (Poliakov et al. 2005; Redmond et al. 
2005). 
 
1.4.1 RPE65 involvement in the regeneration of 11-cis retinal 
 
Studies on RPE65 deficient mice revealed that RPE65 is necessary for the 
production of the visual chromophore 11-cis retinal in the visual cycle. Namely, RPE65 
deficient animals show over-accumulation of retinyl esters in RPE and undetectable 
levels of rhodopsin / 11-cis retinal, indicating a blockade of the visual cycle.  
Recently, Jin at all (Jin et al. 2005) employing an unbiased cDNA expression 
screen identified RPE65 as isomerase and by demonstrating catalytic activity in 
mammalian and insect cells confirmed its enzymatic function in the visual cycle. 
Additional studies have confirmed the role RPE65 as the isomerohydrolase in the 
retinoid visual cycle (Moiseyev et al. 2005; Redmond et al. 2005). Furthermore, 
mutational analysis of iron-binding histidine residues, based on analogy with other 
carotenoid oxygenases, identified that the iron-coordinating residues of the RPE65 are 
essential for its catalytic activity and stability (Redmond et al. 2005; Takahashi et al. 
2005). 
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1.4.2 RPE65 mutations in early-onset severe retinal dystrophy (EOSRD) and 
Leber congenital amaurosis (LCA) 
 
More than 80 disease-associated mutations have been identified in the Rpe65 
gene so far (for a full list see (Zernant et al. 2005)). The broad spectrum of mutations 
includes point mutations, splice-site defects, rearrangements, deletions, and insertions. 
Mutations in Rpe65 are inherited in a recessive manner and it is estimated that they 
account for approximately 11% of all autosomal recessive childhood-onset retinal 
dystrophy cases (Thompson et al. 2000). The patients suffering from mutations in the 
Rpe65 gene are diagnosed as arRP (autosomal recessive), juvenile RP, EOSRD 
(early-onset severe retinal dystrophy) or LCA (Leber congenital amaurosis). This rather 
unclear nomenclature reflects the phenotypic heterogeneity underlying the disease (as 
in many RP cases), but to a certain extent it results from nonuniform diagnostic criteria 
used by clinicians. RP is the diagnosis given to patients with photoreceptor 
degeneration who have good central vision within the first decade of life, and the 
diagnosis of LCA is given to patients who are born blind or lose vision within a few 
months after birth. Most patients suffering from mutations in the Rpe65 gene are 
diagnosed early in childhood as severely visually impaired, with congenital night 
blindness and nystagmus, and no photophobia. Early in infancy patients have severely 
restricted visual fields, with nondetectable dark-adapted ERG and severely diminished 
light-adapted ERGs. Most of the patients have useful vision in the first decade of life 
sufficient to attend elementary school. However, vision is gradually lost resulting in 
blindness almost invariably in the third decade of life.  
Two naturally occurring (rd12 mouse and Briard dog) and the genetically 
engineered RPE65 knock-out mouse (Rpe65-/-) models reported so far have been 
useful in the delineation of the RPE65 protein function in the visual cycle. These 
models have meanwhile been used in gene replacement therapy experiments to 
restore rod and cone photoreceptor function. The above models represent a “null 
situation” in which the visual cycle has never been functional due to the lack of 11-cis 
retinal synthesis - as a result of the absence of functional RPE65 protein. However, 
more than 60% of Rpe65 mutations reported in patients are missense mutations. Some 
of the missense mutations presumably produce mutant versions of the encoded protein 
with some residual function. This hypothesis is supported by the in vitro analysis of 
mutations associated with LCA / EOSRD. These mutations cause partial or total loss of 
isomerization activity, which is in direct relation to their clinical effect (Redmond et al. 
2005). It is not clear how missense mutations contribute to the human pathology.  
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Recently, three consanguineous families carrying the R91W mutation in Rpe65 
have been characterized (see Figure 6) (El Matri et al. 2006). All affected family 
members were homozygous for the mutation. The pathology reported is in line with the 
typical clinical picture described above for EOSRD but not LCA. As the R91W mutation 
is described as the most common missense mutation in the Rpe65 gene (Thompson et 
al. 2000) and as the pathology caused by it may not be accessible in the knock-out 
animal models described so far, it was of importance to develop a model mimicking the 
disease caused by this missense mutation.   
 
Figure 6  Fundus color photography from patients affected by R91W mutation in Rpe65 gene 
Two patterns identified in R91W patients representing earlier (pattern 1) and later (pattern 2) stages of 
disease. Pattern 1: Confluent white dot deposits, grey discoloration of the RPE and peripapillary atrophy. 
Pattern 2: Mid-peripheral pigmented clumps of different sizes either entirely pigmented or with central 
depigmentation.  
Adapted from (El Matri et al. 2006) 
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1.5 AIMS OF THE PROJECT 
 
The R91W mutation is the most common missense mutation in Rpe65 reported 
in human patients (Thompson et al. 2000). Patients affected by this mutation have 
useful vision in the first decade of life discriminating them from LCA patients (null 
mutation in Rpe65) that are blind from birth. All available RPE65 animal models are 
functional knock-out models and thus models for LCA. It is not known how missense 
mutations contribute to the pathology. Mouse and human Rpe65 share 94% identity 
and position 91 is in one of the most conserved regions in the RPE65 protein. 
The present work was elaborated in order to mimic human retinal dystrophy 
caused by a missense mutation in RPE65 thereby providing a tool to study molecular 
mechanisms of the human disease process that may ultimately lead to blindness. To 
do so, following steps were undertaken:  
- generation of RPE65-R91W knock-in mouse 
- characterization of the visual cycle in mutant mice 
- visual function assessment 
- analysis of the resulting pathology 
- comparison to the null situation  
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2 MATERIALS AND METHODS 
 
2.1 Generation of the R91W knock-in mice 
 
In order to generate a mouse carrying the R91W mutation in the Rpe65 gene, a 
strategy using homologous recombination (HR) in embryonic stem (ES) cells has been 
employed to replace the wild-type with a modified Rpe65 gene. The replacement 
(targeting) vector was designed to possess several basic features: i) a substantially 
large stretch of genomic DNA containing the desired mutation leading to the R91W 
substitution to be introduced by HR; ii) a positive selection marker (neomycin 
resistance gene, neo), which was flanked by loxP sites in order to enable cre-mediated 
deletion of neo in further steps; iii) a negative selection marker (diphtheria toxin, DT) 
cassette; iv) a single restriction site in the plasmid backbone of the targeting vector for 
linearization (XhoI), and v) a marker for detection of the HR event (PCR and Southern 
blotting). A PCR-based approach was used as a primary screening method. Two 
constructs have been prepared: a targeting and a control construct. The general 
strategy applied is shown in Figure 9. Mice were generated in collaboration with Dr. 
Birgit Lederman (University of Zurich, Zurich, Switzerland). 
2.1.1 RPE65 genomic source DNA  
 
Genomic DNA used in our experiment was derived from the 129/Sv mouse strain 
and consisted of 2.7 kb of the 5’ flanking region followed by the first 6 exons with 
intervening introns of the Rpe65 gene. These 12.7 kbs were divided in two contiguous 
subclones: E1-12 containing exons 1-3 and clone E2-8 containing exons 4-6 (Figure 
7A); cloned into EcoRI restriction site of pBluescriptII SK(-) vector (provided by T.M. 
Redmond, National Eye Institute, Bethesda, USA) (Boulanger et al. 2001). 
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Figure 7 Rpe65R91W site-directed mutagenesis 
A, Genomic organization of the mouse Rpe65 gene. Two contiguous clones: E1-12 and E2-8 cloned into 
EcoRI restriction site of pBluescript II SK(-) containing the first six exons served as source of genomic 
DNA used for construction of the targeting vector. B, Clone E2-8 containing exons 4-6, was used as 
template for site-directed mutagenesis. The forward primer was designed to hybridize in the plasmid 
backbone. The degenerate reverse primer contained two point mutations spanning codon 91 of Rpe65 
(indicated in lowercase letters) and spanned a BsrDI restriction site suitable for excision of mutated 
fragment. The PCR fragment was cloned into PCR2.1-TOPO vector. C, Triple ligation to introduce the 
R91W mutation into exon 4: The EcoRI/BsrDI (281 bp) restriction fragment derived from site-directed 
mutagenesis was ligated with the BsrDI/NheI (626 bp) restriction fragment containing the partial exon 4 
and exon 5 of the genomic Rpe65 DNA and subcloned into the EcoRI/XbaI polylinker region of the 
pCR2.1-TOPO vector. Ligation of the complementary XbaI and NheI sticky ends resulted in loss of the 
NheI site in genomic sequence. For the introduction of the R91W mutation into the targeting vector the 
EcoRI/NsiI (525 bp) restriction fragment has been excised. 
* denotes presence of R91W mutation in exon 4. 
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2.1.2 The neomycin (neo) and diphtheria toxin (DT) resistance genes 
 
The Neo cassette flanked by mutant loxP sites (floxed-neo) in the direct repeat 
orientation and the diphtheria toxin (DT) negative selection marker were obtained from 
A. Zurlinden (University of Zurich, Zurich, Switzerland). Prior to integration of this 
cassette into the Rpe65 DNA, a Klenow fill-in reaction followed by blunt-end ligation 
was used to remove the BamHI and EcoRI restriction sites from the floxed-neo 
cassette. Since further cloning steps required the use of the respective enzymes, this 
step greatly facilitated the cloning procedure. 
 
2.1.3 Site-directed mutagenesis 
 
Clone E2-8 served as template for the PCR targeted site-directed mutagenesis 
(Figure 7B). In humans, transition of arginine to tryptophan at position 91 (R91W) is 
caused by a single point mutation (TGA>TGG) in the Rpe65 gene. Mouse and human 
codons differ for the respective arginine. Two point mutations were introduced into the 
mouse R91 codon (CGA>TGG) using a respective reverse primer (C AGT CAT TGC 
CCA AAC ATA AGC ATC AGT GCG GAT GAA TCT GAA GAC TAT TGA GAA ATG 
GA; underlined codon denotes position 91) to obtain the R91W mutation (Figure 7B). 
The forward primer was designed in the plasmid backbone (GCG CGT AAT ACG ACT 
CAC TA). The PCR was performed with proofreading DyNAzyme EXT DNA 
Polymerase (Fynnzyme, Espoo, Fi) and PCR conditions were as follows: the initial 
denaturation at 94 oC for 4 min, followed by 30 cycles (94 oC/30 sec; 62 oC/45 sec and 
72 oC/45 sec) and final extension at 72 oC for 10 min. The specificity of the PCR 
reaction was verified by gel electrophoresis, which revealed the expected 363 bps 
band and no additional products.  
The PCR product containing R91W was ligated into a PCR2.1-TOPO vector 
(#45-0641, Invitrogene, Basel, Switzerland) according to the manufacturer’s protocol 
and propagated in TOP10 One Shot (Invitrogene, Basel, Switzerland) chemically 
competent bacterial cells. Plasmid DNA was isolated from bacterial cultures using the 
QIAprep Spin Miniprep Kit (#27106, Qiagen, Basel, Switzerland). The insert was 
verified by restriction enzyme digestion and sequencing resulting in one positive clone 
containing the correct sequence. The EcoRI/BsrDI (281 bp) fragment excised from the 
positive clone and a BsrDI/NheI (626 bp) fragment containing the partial exon 4 and 
exon 5 of the genomic Rpe65 DNA were subcloned into the EcoRI/XbaI polylinker 
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region of the pCR2.1-TOPO vector (Figure 7C). This triple ligation step used 
complementarity of XbaI and NheI sites that resulted in loss of the NheI site in the 
genomic sequence. Finally, the EcoRI/NsiI (525 bp) fragment containing the R91W 
mutation was prepared for reintroduction into the targeting construct (see Figure 8; 
STEP 2B).  
 
2.1.4 Design of control and targeting construct 
 
A single NheI restriction site in clone E2-8 approximately 650 bps downstream of 
the codone 91 in exon 4 was used for the integration of the neo cassette. The neo 
cassette was excised by XbaI and ligated into complementary NheI site of E2-8 
plasmid producing a control construct (Figure 8; STEP 1). This control construct was 
used to establish the PCR conditions for HR screening (see section 2.1.6) and for 
further construction of the targeting vector.  
In the following step Rpe65 DNA containing the integrated neo cassette was 
truncated at the 3’ region (Figure 8; STEP 2a) and an EcoRI/NsiI DNA fragment 
containing the R91W mutation was introduced (Figure 8; STEP 2b). This resulted in the 
so-called short arm of the targeting vector. For the long arm of the targeting construct 
the 5’ region containing exons 1-3 (from vector E1-12) were ligated to the EcoRI site of 
the short arm (Figure 8; STEP 3). In the final step the DT cassette was introduced 
(Figure 8; STEP 4) to serve as a negative selection marker. A single XhoI site in the 
plasmid backbone was used for linearization prior to electroporation. Each step of 
ligation was verified by digestion with different restriction enzymes. A restriction pattern 
was predicted from sequences published in the MGI database 
(http://www.informatics.jax.org/) and NCBI nucleotide database 
(http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=Nucleotide). To make sure that the 
targeting vector was correctly constructed, the final targeting construct carrying the 
R91W mutation was sequenced. 
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Figure 8 Construction of R91W targeting vector 
STEP 1; Incorporation of the floxed Neo cassette into clone E2-8 resulting in creation of the control 
construct used to establish the PCR conditions to detect the HR event. Arrows in the control construct 
represent the positions of the two nested primer pairs used. STEP 2a; truncation of the 3' region of the 
control construct to create the short arm of the targeting construct suitable for screening of a HR event by 
PCR. STEP 2b; introduction of the R91W mutation contained in the EcoRI/NsiI (525 bp) fragment (see 
Figure 7C). STEP 3; addition of the 5' region contained in clone E1-12 (exons 1-3) to create the long arm 
of the construct. STEP4: Incorporation of the diphteria toxin (DT) cassette as negative selection marker at 
the 5’ end resulting in creation of the final targeting construct. The positions of the most relevant restriction 
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enzyme sites are indicated. The unique XhoI restriction site was used for linearization of the vector prior to 
electroporation into ES cells. 
 
2.1.5 Electroporation of embryonic stem (ES) cells 
 
The XhoI-linearized control, targeting or unrelated vector were electroporated into 
isogenic TC-1 embryonic stem (ES) cells derived from 129Sv mice (Deng et al. 1995; 
Katschinski et al. 2003). For this purpose 30 µg of vector and 5x106 TC- ES cells were 
pulsed at 240 V / 500 µF (Bio-Rad Gene Pulser, Reinach, Switzerland). After 48 hours 
of recovery, selective media containing 200 µg/ml G418 (Calbiochem, La Jolla, Calif.) 
was added to the ES cells for additional 8 days. 10 days following electroporation 
G418-resistant colonies were picked. Genomic DNA from G418-resistant ES clones 
was analyzed for correct vector integration by PCR and Southern blotting as described 
in section 2.1.6. 
 
2.1.6 Assessing the ES cells for homologous recombination  
 
To establish the PCR conditions for detection of HR event, ES cells were 
electroporated with control construct carrying the neo gene (Figure 8) and with a 
unrelated construct and cultured as described in section 2.1.5. Single G-418 resistant 
colonies were picked and one colony transfected with the control construct was pooled 
with 7 or 11 unrelated  transfected ES colonies to test for PCR sensitivity. Genomic 
DNA was isolated and PCR conditions were tested.  
For the detection of the correctly integrated neo cassette, two primer pairs have 
been selected to allow a nested PCR approach (Figure 9B; Table 2). For the neo1 
primer pair the forward primer was designed within the neo cassette and the reverse 
primer was positioned outside of the targeted DNA sequence (Figure 9B; Table 2). To 
further minimize any false positive result, a nested neo2 primer pair was created within 
the same area, thus only correctly integrated DNA should be detectable by PCR 
(Figure 9B; Table 2). A Taq primer pair was used to detect the presence of the R91W 
mutation. This pair produced a 998 bp fragment from both, wild-type and mutant DNA. 
Only the wild-type DNA amplicon included a TaqI restriction site, resulting in 619 and 
379 bp fragments after incubation with TaqI restriction enzyme. 
DNA from G418-resistant ES cells was analyzed by Southern blotting. An 
external 3’ BamHI probe (759-bp) was random-labeled using the DIG labeling kit 
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(#1585614, Roche Diagnostics, Mannheim, Germany).  Genomic ES cell DNA was 
digested overnight with EcoRI and electrophoresed on a 0.8% agarose gel. DNA 
samples were transferred onto a nylon membrane by a capillary method. The 
membrane was incubated with the DIG-labelled probe. Fragments corresponding to 
wild-type and knock-in alleles (5.6 and 7.7 kb, respectively) were detected by 
enhanced chemiluminescence (Figure 9B). 
 
2.1.7 Blastocyst injection, assessment of germ line transmission and 
crossbreeding  
 
10-20 positive ES clones, containing a homologously recombined R91W 
mutation, were injected into blastocyst originating from C57BL/6 mice. 10 blastocysts 
per uterus were transferred into foster NMRI mothers. 2 chimeric males were born. 
Germ line transmission was tested by breeding the chimeric males with C57BL/6 
females and positive selection was performed by coat color assessment (agouti color 
was expected for positive offspring) and PCR genotyping using neo1, neo2 and TaqI 
primer pairs (section 2.1.6, Table 2 and Figure 9B).  
 
Table 2 PCR primers used for genotyping of different mouse strains  
Primer 
name 
Forward 
(5’-3’) 
Reverse 
(5’-3’) 
Product Size 
(bp) 
neo1*+ AGCAGCCTCTGTTCCACATAC GATGAGCAGTGGCACCATTG 1513 
neo2*+ CTCAGTATTGTTTTGCCAAG GATCAACCTGTAGAATGAAAG 1445 
Cre* GGACATGTTCAGGGATCGCCAGGCG GCATAACCAGTGAAACAGCATTGCTG 268 
Taq** GCTGGTCTTGCCTGTATCA GTCAGAGACAGTGCTGTGTT 998 
Rpe65-/-  GATGTGGGCCAGGGCTCTTTGAAG GGGAACTTCCTGACTAGGGGAGG 459 
Rpe65+/+ GATGTGGGCCAGGGCTCTTTGAAG CCCAATAGTCTAGTAATCACAGATG 546 
Rho-/- TCTCTCATGAGCCTAAAGCT TTCAAGCCCAAGCTTTCGCG 310 
Rho+/+ TCTCTCATGAGCCTAAAGCT ATGCCTGGAACCAATCCGAG 470 
*primers related to the generation of R91W knock-in mice 
** Taq primer pair used to genotype R91W mice. Genotyping included digestion of the 998 bp PCR 
product by TaqI restriction. This digestion results in generation of 619 and 379 bp fragments in wild-type 
animals, or no cleavage in R91W knock-in animals.  
*+The genotyping using neo1 and neo2 included: a first PCR using the neo1 primer pair amplified for 20 
cycles followed by the nested PCR using neo2 primer pair amplified for 35 cycles.  
Primers for genotyping the Rpe65 and Rho mice are as previously described (Humphries et al. 1997; 
Redmond and Hamel 2000) 
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Following the confirmation of germ line transmission, the chimeric male was 
bread to 129S6 females to propagate the line on a co-isogenic background. This 
breeding resulted in the generation of a heterozygous Rpe65R91Wneo line. The genotype 
was confirmed by PCR using neo1, neo2 and TaqI primer pairs. 
For in vivo removal of the neo resistance cassette, Rpe65R91Wneo mice were bred 
with deleter mice expressing cre recombinase in their germ line (129S6-TgN(Prnp-
GFP/Cre)1Blw/J (Scheel et al. 2003)). The Rpe65R91Wneo mice were kept on a cre-
deleter background for 2 generations to ensure complete excision of the floxed-neo 
cassette. The deletion of the neo cassette was confirmed by PCR genotyping using 
neo1, neo2 and cre primer pairs (see Table 2). Finally, the resulting heterozygous 
R91W/wt offspring was intercrossed to obtain R91W homozygous mice. The 
genotyping of the final R91W knock-in mice was preformed by PCR on tail genomic 
DNA using the TaqI primer pair as described in Table 2. 
 
2.2 Animals 
 
All procedures concerning animals were in accordance with the regulations of the 
Veterinary Authority of Zurich and with the statement of ‘The Association for Research 
in Vision and Ophthalmology’ for the use of animals in research. All animals were 
raised in cyclic light (12:12 h; 60 lux at cage level). The cre expressing mice 129S6-
TgN(Prnp-GFP/Cre)1Blw/J (Scheel et al. 2003) and corresponding wild-type mice 
(129S6) were purchased from the Jackson Laboratory (Bar Harbor, USA). Rhodopsin 
deficient mice (Rho-/-) were generously provided by M. Seeeliger (University Eye 
Hospital, Tuebingen, Germany)(Humphries et al. 1997). Rpe65 deficient mice (Rpe65-/-
) were maintained at the University Hospital Zurich (Redmond et al. 1998). The double 
mutant R91W;Rho-/- and Rpe65-/-;Rho-/- mice were generated by classical breeding 
schemes. Genotyping was performed by PCR on tail genomic DNA, using the primers 
shown in Table 2.  
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2.3 RNA isolation, reverse transcription and quantitative real-
time PCR 
 
Retinas were removed through a slit in the cornea. The remnant eyecup tissue 
containing RPE was isolated separately. The isolated tissue was immediately frozen in 
liquid nitrogen and stored at -70 °C until RNA preparation. RNA was isolated using 
RNeasy Mini Kit (Qiagen, Hilden, Germany) following the manufacturer’s protocol. 
Briefly, a retina was homogenized in 350 µl lysis buffer containing β-mercaptoethanol 
by using a syringe and passing the lysates 10 times trough a 21-G needle. After 
addition of 70% ethanol, the lysate was applied to the RNA-binding column. To 
minimize DNA contamination, nucleic acids bound to the membrane were treated with 
DNase. After several steps of washing, RNA was eluted with 50 µl of RNase-free water 
and its concentration was measured by spectrophotometry.  
For reverse transcription (RT) typically 650 ng of RNA was used. RT-PCR was 
carried out by using oligo dT and M-MLV reverse transcriptase (Promega, Madison, 
USA) in a final volume of 25 µl. The RT was performed at 37°C for 1.5 h, followed by 
incubation at 65°C for 10 min. cDNA corresponding to 10 ng of total RNA was amplified 
with specific primers in subsequent PCR reactions (Table 3). 
 
Table 3 Primers and PCR conditions used for quantitative gene expression analysis  
Gene Forward primer (5’-3’) 
Reverse primer 
(5’-3’) 
Ann. 
temp.(oC) 
Elong. 
time (s) 
Size 
(bp) 
β-actin  CAACGGCTCCGGCATGTGC CTCTTGCTCTGGGCCTCG 58 7 153 
SWL opsin* TGTACATGGTCAACAATCGGA ACACCATCTCCAGAATGCAAG 58 7 153 
MWL opsin* CTCTGCTACCTCCAAGTGTGG AAGTATAGGGTCCCCAGCAGA 58 7 154 
Rod opsin TTTTATGTGCCCTTCTCCAACG ATGATAGCGTGATTCTCCCCG 60 19 440 
GNAT1* GAGGATGCTGAGAAGGATGC TGAATGTTGAGCGTGGTCAT 58 9 209 
GNAT2* GCATCAGTGCTGAGGACAAA CTAGGCACTCTTCGGGTGAG 58 8 192 
Rpe65** ATGACTGAGAAGAGGATTGTC CTGCTTTCAGTGGAGGGATC 60 15 366 
MCT3 GGCTCAACCCTAAATCCAGA CTTCGGAGTTTCCTCACCAG 58 4 75 
FGF2 TGTGTCTATCAAGGGAGTGTGTGC ACCAACTGGAGTATTTCCGTGACCG 62 7 158 
GFAP CCACCAAACTGGCTGATGTCTAC TTCTCTCCAAATCCACACGAGC 62 10 240 
Casp-1 GGCAGGAATTCTGGAGCTTCAA GTCAGTCCTGGAAATGTGCC 60 6 138 
* primers described in(Znoiko et al. 2005); ** primers described in (Redmond et al. 1998) 
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cDNA quantification was carried out by real-time RT-PCR using either SYBR 
Green JumpStart Taq ReadyMix kit (Sigma, Saint Louis, USA) or the LightCycler 480 
Sybr Green I Master kit (Roche, Mannheim, Germany). Amplifications were performed 
using a Light Cycler instrument (Roche, Mannheim, Germany). The PCR included a 
hot start denaturation at 95 °C for 10 minutes, followed by 45 cycles, with melting at 95 
°C for 5 seconds, annealing for 8 seconds and elongation at 72 °C (annealing 
temperatures and elongation times indicated in the Table 3). Melting curve analysis 
was performed (0.1 °C/sec increase from 65 °C to 95 °C, with continuous fluorescence 
readings) at the end of 45 cycles, to control for the specificity of the reaction. For the 
relative quantification of gene expression, mRNA levels were normalized to β-actin for 
retinal samples or to MCT3 (monocarboxylic acid transporter 3) for eyecups using the 
ΔΔCT (comparative threshold cycle) method. Relative values were calculated using a 
respective calibrator sample as indicated in the results. Each reaction was run in 
triplicates. 
 
2.4 Western blotting 
 
The isolation of retinal and eyecup proteins was as follows: the eye was 
enucleated and lens and vitreous were removed through a slit in the cornea. The retina 
was separated from eyecup and tissues were separately homogenized in Tris buffer 
(0.1 M, pH 8.0) using an ultrasound tip at 4 oC. The homogenate was centrifuged for 1 
min at 1000 x g, the supernatant was analyzed for its protein content (Bradford Assay, 
Bio-Rad), mixed with SDS sample buffer, and heated for 10 min at 70 oC. 
The isolated proteins were subjected to SDS-PAGE and blotted onto 
nitrocellulose. The membranes were probed with primary antibodies, followed by 
horseradish peroxidase-conjugated secondary antibodies. The primary antibodies used 
were: rabbit anti-Rpe65 (pin5; 1:2’000); rabbit anti-RGR (pin3; 1:5’000); mouse anti-
LRAT (1:1’000; gift from K. Palczewski University of Washington, Seattle, USA); rabbit 
anti-Cralbp (UW55; 1:10’000, gift from J. C. Saari, University of Washington, Seattle, 
USA). Protein bands were visualized with the addition of an enhanced 
chemiluminescent substrate (PerkinElmer, Boston, USA) and exposure to Super RX 
film (Fujifilm, Dielsdorf, Switzerland). At least three animals were analyzed per 
condition and genotype. Quantification of RPE65 immunoreactivity was done using 
anti-rabbit secondary antibodies conjugated to IR dye 800 (Rockland 
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Immunochemicals) and quantified using the Odyssey infrared imaging system (LI-COR 
Biotechnology, Cambridge, UK) with β-actin as standard (Santa Cruz, USA). 
 
2.5 Rhodopsin measurements 
 
Rhodopsin content was analyzed as described earlier (Wenzel et al. 2005). The 
mice were dark adapted for 24 h, sacrificed under dim-red light and retinas - isolated 
through a slit in the cornea - were placed in 1 ml of distilled H2O. After 10 min of 
centrifugation at 15’000 x g, the pellet was mixed with 700 µl of 1% 
hexadecyltrimethylammonium bromide (Fluka Chemie, Buchs, Switzerland) and 
homogenized with a Polytron for 10 sec. The homogenate was centrifuged for 10 min 
at 15’000 x g, and the supernatant was collected. The absorption at 500 nm was 
measured before and after exposure to bright white light (20,000 lux for 1 min). The 
amount of rhodopsin present per retina was calculated using the following formula 
derived from the Lambert-Beer equation: rho = V x c = V x ∆A500 / (ε500 x l x n). rho is 
the amount of rhodopsin per retina [mol]; V, the volume of sample [l]; c, the 
concentration of rhodopsin per retina [M]; ∆A500 is the difference between absorption 
before and after bleaching measured at 500 nm; ε500, the extinction coefficient of 
rhodopsin at 500 nm [4.2 x 104 M-1cm-1]; l, the path length of the cuvette [cm]; and n is 
the number of retinas. At least three animals were analyzed per condition and 
genotype.  
 
2.6 Rhodopsin regeneration kinetics 
 
The kinetics of rhodopsin regeneration after bleaching was analyzed in mice that 
were dark adapted for 24 hours. 30-60 min prior to light exposure, pupils were dilated 
(Cyclogyl 1%; Alcon, Cham, Switzerland; and phenylephrine 5%, Ciba Vision, 
Niederwangen, Switzerland) under dim red light (≥650 nm). Animals were exposed for 
10 min to 5’000 lux of fluorescent white light (TLD-36 W/965 tubes; Philips, Hamburg, 
Germany; UV-impermeable diffuser). Following illumination mice were placed in 
darkness for the times indicated in the results and rhodopsin content was analyzed as 
described above. Non-exposed mice served as dark-controls. At least three animals 
were analyzed per condition and genotype.  
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2.7 Histology 
 
Animals were sacrificed and the superior portion of the eye was marked. The 
enucleated eyes were fixed in 2.5% glutaraldehyde prepared in 0.1 M cacodylate 
buffer. After overnight fixation, the cornea, lens and vitreous were removed and 
superior part of the eye was separated from inferior by a cut through the optic nerve 
head. The tissue was washed in 0.1 M cacodylate buffer two times for 15 min, 
postfixed in 1% osmiumtetroxid for 1 hour, and dehydrated in ethanol series (30% 5 
min, 50% 15 min, 70% 15 min, 96% 15 min, 100% 3 x 15 min). The tissue was 
incubated in propylenoxid (2 x 15 min), propylenoxid/Epon 812 mix (1:1, 3 h), followed 
by pure Epon (overnight). The next day tissue was embedded in Epon with addition of 
N-benzyl-dimethylamin as catalyzer of polymerization and incubated at 60 oC for 2 
days. For light microscopy, 0.5 µm thin sections were prepared from the inferior central 
retina, counterstained with methylene blue, and analyzed using a microscope 
(Axiovision, Zeiss, Germany). For electron microscopy, sections (50-60 nm) were 
contrasted with 4% uranyl acetate in 50% EtOH and 2.6% lead nitrate in 1 M NaOH. 
Sections were analyzed using a Hitachi 7000 electron microscope (Hitachi, Tokyo, 
Japan). 
 
2.8 Immunofluorescence 
 
Animals were sacrificed and the superior part of the eye was marked for 
orientation. The enucleated eyes were immersed in cryoprotective medium (Jung, 
Nussloch, Germany), frozen in liquid nitrogen and stored at -70 oC until further use. 10-
20 µm sections were cut temporal to nasal trough the optic nerve head. Sections were 
dried overnight at room temperature, fixed in cold acetone for 10 min, washed in PBST 
(PBS + 0.05% Triton X-100) for 2 x 5min at room temperature (RT). After blocking in 
PBST containing 10% normal goat serum (NGS) for 1h at RT, sections were incubated 
with the anti-rabbit RPE65 primary antibody (1:500) in PBST containing 3% NGS at 4 
oC, overnight. Sections were washed 3 x 10min in PBST and secondary antibodies 
(Cy3 conjugated; Jackson ImmunoResesarch, Soham, UK) were applied in PBST 
containing 3% NGS for 1-2h at RT. Sections were washed 2 x 10min in PBST and 1 x 
in PBS and rinsed in water before they were covered with PBS containing 75% glycerol 
and 30 mg/ml diazo-bicyclo-octane. Immunofluorescence was analyzed on a 
microscope (Axiovision, Zeiss) and documented using a digital imaging system. 
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2.9 Cone quantification 
 
For cone quantification, eyes were marked nasally, enucleated and perforated at 
the cornea to allow better penetration of the fixative. After fixation for 1h in 4% PFA (in 
PBS) the eyes were cryoprotected in 25% sucrose solution. The eyes were embedded 
in albumin from hen egg white (Fluka, Buchs, Switzerland) and cut dorsal to ventral 
trough the optic nerve head. 14 µm sections slides were blocked for at least 1h at room 
temperature in PBS containing 0.2% Triton and 10% NGS (Dako, Zug, Switzerland) or 
10% normal horse serum (NHS) (Jackson Immunoresearch). The primary and 
secondary antibodies were incubated in PBS containing 0.2% Triton and 2% NGS or 
2% NHS. 
Rabbit anti-GNAT2 (Santa Cruz, USA) was incubated overnight at room 
temperature at 1:100; goat anti-SWL-opsin (Santa Cruz, USA) and rabbit anti-MWL 
(Chemicon, Temecula, CA, USA) overnight at 4ºC at 1:1000. Secondary antibodies 
goat anti-rabbit linked to FITC (1:100, Jackson Immunoresearch, Westgrove, PA, USA) 
or Cy3 (1:500, Jackson Immunoresearch) were incubated 1 hour at room temperature. 
For immunolabelling of the anti-SWL-opsin, donkey anti-goat-Cy3 (1:1000, Jackson 
Immunoresearch) was used. Before examination, sections were counterstained with 
4',6-diamidino-2-phenylindole dilactate (DAPI, Molecular Probes) and mounted with 
Mowiol 4-88 Reagent (VWR International AG, Lucerne, Switzerland). 
The sections trough the optic nerve e.g. the most transversal ones were chosen 
to quantify the number of cells positive for GNAT2, MWL and SWL-cone opsins, 
respectively. The immunoreactive outer segments were counted from periphery to 
periphery using a BX60 microscope equipped for epifluorescence (Olympus Suisse 
SA, Aigle, Switzerland) and coupled to the analySIS® 3.0 software (Soft Imaging 
System). At least 4 eyes per condition and genotype were analyzed. 
 
2.10 HPLC determination of retinoids 
 
HPLC profiling of retinoids was performed in mice dark adapted for 24 hours. All 
steps were carried out under dim red light. Animals were sacrificed, lens and vitreous 
were removed from the eye through a slit in cornea. The rest of the tissue containing 
retina and eyecup was snap frozen in liquid nitrogen until further analysis. 
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The tissue was transferred into 200 µl of 2 M NH2OH (pH 6.8) (results in 
formation of retinaloximes) and 200 µl of methanol and was homogenized by 
sonification (5 bursts for 5 s, 20% of maximum power, Sonoplus, Bandelin, Berlin, 
Germany), followed by incubation for 10 min at RT. Then, 400 µl acetone were added. 
Extraction was performed three times with 500 µl petroleum ether each. The collected 
organic phases were dried on speedvac and dissolved in the HPLC solvent (n- 
hexane/ethanol, 99.5:05). HPLC analyses was performed on a Hypersil 3 µm (Knaur, 
Germany) on a System Gold (Beckman Instrument, Fullerton, USA) equipped with a 
multidiode array (model 166, Beckman) and the System Gold Nouveau software 
(Beckman). The reference substances all-trans, 13-cis, and 9-cis retinal were 
purchased from Sigma (Sigma, Saint Louis, USA); 11-cis retinal was isolated from 
dark-adapted bovine eyes. The corresponding retinols and oximes were obtained by 
reducing with NaBH4 or reaction with NH2OH, respectively. For quantification of the 
molar amounts, peak integrals were scaled with defined amounts of reference 
substances. Peak integrals were calculated using the 32 Karat software (Beckman). 
 
2.11 ERG functional tests 
 
The ERGs were performed according to previously described procedures 
(Seeliger et al. 2001). Briefly, mice were dark-adapted overnight before the 
experiments. Anesthesia was induced by subcutaneous injection of ketamine (66.7 
mg/kg) and xylazine (11.7 mg/kg). Silver needle electrodes served as reference 
(forehead) and ground (tail) electrodes, and gold-wire ring electrodes as active 
electrodes. The ERG equipment consisted of a Ganzfeld bowl, a DC amplifier, and a 
PC-based control and recording unit (Toennies Multiliner Vision; Jaeger/Toennies, 
Höchberg, Germany). The pupils were dilated and single white-flash recordings were 
obtained from both dark-adapted (scotopic) and light-adapted (photopic) conditions.  
Light adaptation was accomplished with a background illumination of 30 cd/m2 
starting 10 minutes before recording. Single white-flash stimulation ranged from -4 log 
candelas*second per m2 (cd*s/m2) to 1.5 log cd*s/m2 under the scotopic condition, and 
from -2 to 4 log cd*s/m2 under the photopic condition, divided into 10 (scotopic) and 13 
(photopic) steps of 0.5 and 1 log cd*s/m2. Responses were averaged with an inter-
stimulus interval (ISI) of either 5 seconds or 17 seconds (for above 0 log cd*s/m2). At 
least 3 animals were analyzed per genotype and age. 
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3 RESULTS 
 
3.1 Generation of R91W knock-in mice 
 
Gene targeting in mouse ES cells was used to modify exon 4 of the Rpe65 gene 
such that codon 91 changed from arginine to tryptophan (R91W) (Figure 9A). In 
humans, the R91W mutation is caused by a single point mutation (TGA>TGG). 
However, mouse arginine 91 is encoded by CGA codon, therefore two point mutations 
had to be introduced into codon 91 (CGA>TGG). The introduction of these two 
mutations resulted in the loss of a TaqI restriction site, facilitating the genotype analysis 
(Figure 9A, B). 
The gene targeting strategy is shown in Figure 9B. In addition to mouse Rpe65 
genomic DNA carrying the R91W mutation, the targeting vector contained a floxed 
neomycin resistance (neo) and a diphtheria toxin (DT) cassette as selection markers. 
Sequencing of the full genomic DNA insert of the targeting vector confirmed the 
presence of the R91W mutation and the selection markers in an otherwise wild-type 
sequence. After electroporation and selection on G418 medium, positive ES cells were 
identified and characterized in detail by Southern blotting, PCR and PCR restriction 
digestion analysis (Figure 9C and data not shown).  
Correctly targeted ES clones were used to generate germ line competent chimeric 
mice. A chimeric male was mated to isogenic 129S6 females to propagate the line. The 
resulting heterozygous (Rpe65R91Wneo) F1 mice were bred with a germ line Cre-deleter 
mouse line (129S6-TgN(Prnp-GFP/Cre)1Blw) (Scheel et al. 2003) to excise the neo 
cassette (Figure 9B). The resulting offspring was heterozygous for the R91W mutation 
(R91W/wt), and the only foreign sequence remaining was a single loxP site. Finally, we 
interbred the heterozygous (R91W/wt) mice to obtain pure R91W mice. Of note, these 
mice were isogenic to 129S6 control mice, except for codon 91 and the above 
mentioned loxP site. 
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Figure 9 Generation of R91W knock-in mice 
A, Partial sequence of exon 4 wild-type and mutated R91W DNA. Note that two point mutations were 
introduced in the codon for arginine (R) at position 91 to obtain tryptophan (W). This resulted in loss of a 
TaqI restriction site in the mutated DNA (right panel). Sequence data of the targeting vector showing a 
mutant TGG triplet at position 91 (right panel). 
 
B, Schematic representation of the R91W targeting strategy  
I: Partial wild-type Rpe65 allele, with restriction enzyme sites and location of exons (boxes). The restriction 
sites given were used to analyze particular steps in cloning of the targeting vector (see method section). 
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II: Targeting construct containing R91W mutation (indicated as lost TaqI restriction site in exon 4), 
neomycin resistant gene flanked by loxP sites (indicated as triangles) suitable for cre-medated excision, 
and diphtheria resistance cassette (DT). Note the unique XhoI restriction site used for linearization of the 
targeting vector.  
III: Mutated genomic Rpe65 DNA after HR selection containing the neomycin cassette (Rpe65R91Wneo). The 
targeted locus with depicted positions of primers and probes for PCR and Southern blot analyses. Neo1 
and neo2 are nested primer pairs designed to read from the selection cassette into the 3’ short arm 
outside of targeting area. These primers were used to confirm the homologous recombination. The Taq 
primer pair was used to confirm the presence of R91W mutation (see methods). 
IV: The partial R91W mutant allele after the removal of the neo cassette by crossing Rpe65R91Wneo mice 
with the Cre-deleter mice. 
 
C, Genotyping of R91W mutants.  
Upper panel: DNA was isolated from neomycin-resistant ES cell colonies, and analyzed by Southern 
blotting, after digestion by EcoRI, and using 3’external probe as indicated in Figure 9B. Signal from the 
genomic DNA from wild-type (wt) allele is 5.6 kb. A heterozygous Rpe65R91Wneo knock-in (KI) allele gives 
rise to additional 7.7 kb due to the presence of neomycin cassette.  
Middle panel: PCR analysis of the same DNA using neo1 and neo2 nested primer pair. A PCR fragment of 
1145 bps detected in heterozygous Rpe65R91Wneo knock-in due to the presence of the neomycin cassette. 
Lower panel: RFLP-PCR analysis of the same DNA using the Taq primer pair (see Figure 9B). A PCR 
fragment of 998 bps was digested with the TaqI restriction enzyme. In wild-type animals this results in a 
379 and a 619 bp fragments. Heterozygous Rpe65R91Wneo knock-in DNA contains an additional 998 bp 
fragment due to the loss of the TaqI restriction site. This protocol was used for genotyping of the final 
R91W knock-in mice. 
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3.2 Rpe65 expression in the mutant mice 
 
In order to test whether R91W knock-in mice express RPE65, we analyzed its 
expression by quantitative RT-PCR, Western blotting and immunohistochemistry 
(Figure 10A, B and C). While the expression of Rpe65 mRNA was relatively slightly 
reduced in R91W mice (Figure 10A), Western blotting revealed that the steady state 
levels of the mutant protein were reduced by 95% (not shown) as compared to wild-
type control (Figure 10B). Nevertheless, the mutant protein was correctly localized to 
the RPE as described for wild-type mice (Seeliger et al. 2001; Hemati et al. 2005). No 
RPE65 expression could be detected in control experiments using RNA (RT-PCR), 
protein extracts (Western blotting) or tissue (immunohistochemistry) from RPE65 
deficient mice (Figure 10A, B and C). 
We also compared the amount of several proteins (retinal G protein coupled 
receptor, RGR; lecithin retinol acyltransferase, LRAT; and cellular retinaldehyde 
binding protein, CRALBP) that are involved in retinoid recycling and may at least 
functionally be connected to RPE65 (Saari 2000; Van Hooser et al. 2002; Wenzel et al. 
2005). In eyecups of 8 week-old age-matched wild-type, R91W knock-in and Rpe65-/- 
animals the expression levels of these three proteins were similar with a tendency of 
increased LRAT levels in mutant mice (Figure 10B). 
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Figure 10 R91W mutation causes reduced levels of RPE65 
A, Relative mRNA levels of Rpe65 expressed in eyecups of wild-type, R91W, Rpe65-/- and R91W/wt mice 
at 8 weeks of age as determined by real-time RT-PCR. mRNA levels are expressed relative to wild-type 
control, which was set to 1. RNA isolated from 3 independent retinas per age and genotype was amplified 
in triplicates (means ± S.D.).  
B, Western blotting of eyecup proteins from three animals of each genotype (wild-type, R91W and Rpe65-/- 
mice) are shown. Presence of the R91W mutation resulted in reduced amounts of RPE65 
immunoreactivity but had clearly less effects on the protein levels of RGR, LRAT and CRALBP.  
*, unspecific band.  
C, Immunolabeling with a polyclonal antibody to RPE65, demonstrating that the R91W mutant protein is 
expressed in RPE cells only. Note the reduced immunoreactivity as compared to animals expressing wild-
type RPE65 protein. The Rpe65-/- animals served as negative controls and no staining was observed in 
their RPE. 
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3.3 Retinoid analysis 
 
The absence of RPE65 in mice results in the arrest of the visual cycle causing 
accumulation of retinyl esters in the RPE and lack of rhodopsin (Redmond et al. 1998). 
In line with this observation, dramatically reduced protein levels of mutant RPE65 
(Figure 10B) pointed to a similar disturbance of the visual cycle of R91W mice. 
Therefore, we analyzed the retinoid profile in wild-type, R91W/wt heterozygous, R91W 
homozygous and Rpe65-/- mice at different ages. 
The analysis of combined retina and eyecup preparations (see methods section) 
of 4, 8, 12, 24 and 40 week-old animals revealed highly reduced levels of 11-cis retinal 
in R91W homozygous mice, suggesting strong influence of the mutation on the visual 
cycle (Table 4). However, clear differences between Rpe65-/- and R91W mice were 
observed: While 11-cis retinal was not detectable in Rpe65-/- mice at any age, retinas 
from R91W knock-in mice contained between 9.4 and 24 pmol of 11-cis retinal (Table 
4). These numbers represent between 2.5% and 6.3% of the levels found in age-
matched wild-type animals. 
 
Table 4 Retinoid analysis 
All values are given in pmol/eye ±S.D. (n=3). 
 
The presence of reduced amounts of 11-cis retinal in R91W animals indicated 
that the visual cycle is affected but nevertheless might be functional. In addition, we 
GENOTYPE AGE 11-cis retinal 
All-trans 
retinal 
All-trans 
retinol 
Retinyl 
ester 
9-cis 
retinal 
4 380.2±60.1 39.0±11.3 4.2±3.6 30.6±5.6 0 
8 336.1±21.8 34.7±1.6 5.4±9.4 39.2±5.0 0 
12 336.7±32.4 62.6±12.9 0 34.9±4.6 0 wild-type 
24 373.6±75.5 47.9±3.7 2.2±3.8 106.2±27.2 0 
       
4 394.7±22.6 53.4±7.1 6.0±0.8 44.3±5.4 0 
8 371.8±22.1 87.1±4.7 0 55.7±8.4 3.7±0.3 
12 454.8±42.0 52.4±5.5 3.0±3.7 89.6±17.9 0 R91W/wt 
24 337.4±49.0 86.4±15.3 0 108.9±23.3 0 
       
4 24.0±3.0 3.6±0.6 10.4±1.9 420.7±34.5 7.6±0.8 
8 15.4±0.2 4.8±1.5 9.2±5.2 651.9±127.4 9.9±0.9 
12 13.5±0.2 2.7±0.4 13.9±2.7 1542.7±271.8 9.2±1.2 
24 9.4±8.2 1.9±1.7 20.2±17.7 2186.1±160.1 4.3±3.7 
R91W 
40 18.2±4.8 2.2±1.0 12.4±3.4 2107.9±138.9 10.6±3.2 
       
4 0 0 8.6±2.5 271.4±22.8 4.8±1.5 
8 0 1.3±1.2 5.4±1.0 474.9±49.1 8.5±0.7 
12 0 1.9±0.4 14.9±4.1 805.9±57.5 6.7±0.9 
24 0 2.1±0.3 8.5±4.8 1160.6±529.0 10.3±3.8 
Rpe65-/- 
40 0 2.8±1.0 15.6±5.1 2622.9±531.3 13.1±11.2 
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detected a strong accumulation of retinyl esters in the R91W knock-in animals. The 
initial rate of retinyl esters accumulation during the first 24 weeks was almost linear (13 
pmol/day; R2=0.93). By the end of this period, retinyl esters seemed to reach maximal 
levels in R91W mice, as there was no difference between 24 and 40 week containing 
2186 and 2108 pmol/eye, respectively. In Rpe65-/- animals linear accumulation of 
retinyl esters was detected trough all tested time points (9 pmol/day; R2=0.96) and the 
highest levels detected were 2623 pmol/eye in 40 week-old animals. All-trans retinal, 
all-trans retinol and 9-cis retinal levels were comparable in both R91W and Rpe65-/- 
mice. The retinoid content was comparable between wild-type and R91W/wt 
heterozygous animals at all tested time points (Table 4).  
In Rpe65-/- mice, the over-accumulation of retinyl esters results in formation of 
microscopically visible lipid inclusions in the RPE (Redmond et al. 1998). Because 
R91W mice showed increased levels of retinyl esters we analyzed the RPE of 8 week-
old animals of all 4 genotypes by electron microscopy (Figure 11). Unlike in wild-type 
and heterozygous animals, the electron microscopy revealed the presence of 
numerous lipid droplets in RPE of both Rpe65-/- and R91W mice. 
 
 
 
Figure 11 Lipid-like inclusions in R91W mice 
Electron microscopy of the RPE-photoreceptor interface in 8 week-old wild-type, R91W/wt heterozygous, 
R91W homozygous and Rpe65-/- mice. Note that lipid-like inclusions (“L”) and disturbed outer segment 
morphology are present in R91W and Rpe65-/- mice only. 
RESULTS 
 
44 
 
3.4 Rhodopsin content and regeneration 
 
11-cis retinal levels measured in dark-adapted 4 week-old R91W mice 
corresponded to approximately 6% of wild-type levels (Table 4). Likewise, the 
rhodopsin levels in R91W mice, which were dark-adapted for 24 h, were 30 pmol/retina 
or 6% of wild-type rhodopsin levels (Figure 12A). 
The kinetics of rhodopsin regeneration is governed by the expression levels of 
Rpe65 protein (Wenzel et al. 2003; Lyubarsky et al. 2005). Given that lower amounts of 
RPE65 were detected in the RPE of R91W mice (see Figure 10), we expected that 
rhodopsin would regenerate with a slower rate in these animals. To allow for a 
complete regeneration of rhodopsin without daily bleaching, we kept R91W mice in 
darkness for 4, 10 and 22 days. By the time of analysis the mice were 6-7 week-old. 
However, even prolonged dark adaptation did not raise rhodopsin levels significantly. 
Maximal rhodopsin levels detected after 22 days in darkness were 42 pmol, which was 
still less than 10% of the rhodopsin content detected in wild-type animals (Figure 12A, 
see Figure 12C for the wild-type levels).  
In order to test rhodopsin regeneration kinetics following a strong bleach, 6-7 
week-old animals were dark-adapted for 24h and exposed for 10 min to 5000 lux, 
which induces 90% bleach in wild-type animals (Wenzel et al. 2005), and returned 
back to darkness until analysis. Non-exposed R91W mice contained 27 pmol of 
rhodopsin (Figure 12B). Retinas of animals analyzed immediately following the 
exposure contained 1 pmol of rhodopsin. However, even after 5 days of recovery in 
darkness only 44% (12 pmol) of the dark-adapted rhodopsin levels (27 pmol) were 
detectable. Thus, following a strong bleach, regeneration of rhodopsin was 
unexpectedly inefficient and reached a plateau at about half the maximal level.  
Maximal rhodopsin levels were similar in R91W/wt heterozygous and wild-type 
animals; 538 pmol/retina and 560 pmol/retina following 24h of dark adaptation, 
respectively (Figure 12C). The calculated regeneration rates following a strong bleach 
were 6.3 pmol/min in wild-type animals and 4.9 pmol/min in R91W/wt; indicating 
slightly slower rhodopsin regeneration kinetics in R91W/wt animals.  
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Figure 12 Rhodopsin content and regeneration kinetics 
A, Rhodopsin levels in 6 to 7 week-old R91W animals kept in darkness for 1 day or up to 22 days (as 
indicated).  
B, Rhodopsin regeneration of R91W mice. Following 24 h dark-adaptation, R91W mice were exposed to 
5’000 lux for 10 min and the rhodopsin content was analyzed immediately (i) or after different periods of 
recovery in darkness (indicated in days). Unexposed, dark-adapted mice (d) served as controls. 
C, Rhodopsin regeneration of wild-type and R91W/wt heterozygous mice. Following 24 h dark-adaptation, 
mice were exposed to 5’000 lux for 10 min and the rhodopsin content was analyzed immediately (i) or after 
different periods of recovery in darkness (indicated in minutes). Unexposed, dark-adapted mice (d) served 
as controls. Note the slightly slower regeneration kinetics in R91W/wt mice.  
Filled squares, R91W/wt; open squares wild-type.   
All values are given in pmol/eye ± S.D. At least three animals per condition and genotype were analyzed. 
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3.5 Photoreceptor function in R91W mutant mice 
 
The previous experiments showed that R91W mice contain detectable amounts 
of the 11-cis chromophore suggesting that some visual function might be retained. This 
function was tested under scotopic conditions by single flash ERG with increasing light 
intensities ranging from 0.1 mcd*s/m2 to 25 cd*s/m2. ERG recordings revealed that 
higher intensities of light are needed to induce an electrical response in R91W as 
compared to wild-type mice (Figure 13A top panel). By assessing the luminance 
required to generate a half maximal b-wave, the reduction in light sensitivity (Machida 
et al. 2000) of 8 weeks-old R91W mice was determined to be approximately 2.6 log 
units, as compared to wild-type. In age series testing 8, 12, 24 and 40 week-old 
animals the sensitivity threshold remained unaltered, while the b-wave amplitude was 
reduced with increasing age in R91W, which was especially prominent between 12 and 
24 weeks (Figure 13A bottom panel). From 24 weeks of age no further reduction in b-
wave amplitude was detected. Qualitatively, the ERG response of the R91W mice 
showed no distinct a-wave under the conditions applied, suggesting compromised rod 
function (Figure 13A overlay). 
In order to test cone function, ERG responses were recorded under photopic 
conditions by increasing flash intensities from 10 mcd*s/m2 to 25 cd*s/m2 (Figure 13B). 
Notably, there was no difference in threshold sensitivity or in amplitude of the b-wave in 
8 week-old age matched R91W and wild-type control animals (Figure 13B top and 
bottom panel). The remarkable similarity of responses recorded under normally cone-
isolating conditions between R91W and wild-type animals is illustrated by the overlay in 
Figure 13B taken at 25 cd*s/m2 light intensity. However, differences in oscillatory 
potentials in the leading edge of the b-wave and a prominent delayed peak, suggested 
disparities, needing further investigation. 
The threshold light (1 cd*s/m2) exerted responses of similar amplitude at all ages. 
In contrast, and as observed under scotopic conditions, the amplitude of the b-wave at 
higher flash intensities was reduced with age up to 24 weeks (Figure 13B bottom 
panel). Thus, while the sensitivity of the retina was not prone to age-related reduction, 
the maximal response size was.  
Comparison of wild-type and R91W/wt heterozygous animals resulted, as 
expected, in no difference between the genotypes under scotopic (Figure 13C) or 
photopic (Figure 13D) conditions. 
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Figure 13 Assessment of photoreceptor function in R91W mutant mice 
ERG response to single-flash stimuli with increasing flash intensities in 8, 12, 24 and 40 weeks-old R91W 
and compared to wild-type and R91W/wt heterozygous mice. 
A, Scotopic single-flash ERG indicating loss of sensitivity (app. 2.6 log units) in R91W animals as 
compared to 8 week-old wild-type. The b-wave amplitudes were plotted against stimulus intensity at 
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indicated ages (lower panels). A steady decline in the b-wave amplitude was detected with increasing age. 
However, retinal sensitivity as determined by the lowest light intensity triggering a response remained 
largely unchanged. Overlay: Note the absence of a typical a-wave (initial downward deflection) in R91W 
mice (red trace). 
B, Photopic single-flash ERG reflecting an equal sensitivity and similar shape of response between wild-
type and R91W animals at 8 weeks of age. There was a steady decline of the b-wave amplitude with 
increasing age. Overlay: Note the similar shape of the initial responses, with a distinctive second peak in 
R91W mice (red trace). 
C, Scotopic- and (D) photopic- single-flash ERG responses in R91W/wt are comparable to wild-type 
animals. Representative recordings are shown for age matched 12 week-old animals.  
Luminance response function curves are representative traces from individual animals. Each statistical 
graph (lower panels in A and B) represents data obtained from 3 mice e.g. 6 eyes. Boxes indicate the 25% 
and 75% quantile range, whiskers indicate the 5% and 95% quantile and the asterisk indicates the median 
of the data. 
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3.6 Assessment of retinal morphology 
 
The functional tests performed suggested an age-related degenerative process 
caused by the R91W mutation, as the b-wave amplitudes of both: scotopic and 
photopic responses were reduced with increasing age (Figure 13A and B). 
The complete lack of Rpe65 expression leads to a slow retinal degeneration 
evidenced relatively early by less densely packed rod outer segments and at later 
stages by the loss of photoreceptor nuclei (Redmond et al. 1998; Woodruff et al. 2003). 
In human patients carrying mutations in RPE65, the assessment of retinal 
degeneration by optical coherence tomography (OCT) likewise revealed a thinned 
photoreceptor layer (Van Hooser et al. 2000; Lorenz et al. 2004; Jacobson et al. 2005). 
To analyze retinal morphology in more detail, we compared four different 
genotypes (wild-type, R91W/wt, R91W and Rpe65-/-) at various ages (from 4 weeks till 
1 year) using light microscopy (Figure 14). Already at 4 weeks of age the outer 
segments (OS) of R91W and Rpe65-/- mice showed first signs of disorganization 
(Figure 14, top row). Pathological changes affecting photoreceptors such as reduced 
compactness and shortening of outer segments became more obvious as the mice 
grew older. Although the thickness of the outer nuclear layer (ONL) at earlier time-
points was comparable to wild-type, only 5 rows of nuclei remained in the central area 
of 1 year-old mutant animals, as compared to 9-10 rows in one-year old wild-type.  
In comparison to Rpe65-/- animals, R91W mice showed a slightly better 
preservation of OS, at least up to 12 weeks of age (Figure 14, compare last two 
columns). Of note, R91W mice seemed to contain more cone nuclei than respective 
age-matched Rpe65-/- mice especially at early ages, which was further analyzed in 
detail. 
At all ages analyzed, we did not find differences between the retinal morphology 
of wild-type and R91W/wt heterozygous mice (Figure 14; compare first two columns), 
which is in line with a recessive inheritance of the phenotype caused by the R91W 
mutation. Furthermore, no morphologic differences between all tested genotypes were 
detected in the inner retinal structures upon examination by light microscopy. 
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Figure 14 Light microscopic changes in R91W retinas in comparison to wild-type, R91W/wt and 
Rpe65-/- mice at various ages 
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Figure 14, continued 
The thickness of the ONL in R91W mice remained nearly normal until 24 weeks, however, already at 8 
weeks more voids were visible in this layer accompanied by the appearance of pycnotic nuclei. By 1 year, 
only 5 to 6 rows of nuclei remained in the ONL. Disorganization of OS was evident in R91W mice already 
at 4 weeks of age and became more pronounced with ageing. Between 24 weeks and 1 year of age OS 
were greatly shortened. As compared to Rpe65-/- mice, R91W mice showed better retinal preservation at 
least at earlier ages evidenced especially by longer OS and their higher density. Another distinctive feature 
was the relative better preservation of cone nuclei in younger R91W animals as compared to age-matched 
Rpe65-/- mice. At all time-points no difference was observed between wild-type and R91W/wt animals.  
RPE, retinal pigment epithelium; INL, inner nuclear layer; IS, inner segments; ONL, outer nuclear layer; 
OPL, outer plexiform layer; OS, outer segments. Arrow in the ONL indicates cone nuclei characterized by 
less densely packed chromatin. 
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3.7 Cones are functional in R91W 
 
11-cis retinal is the chromophore of both rods and cones. It has been shown that 
ablation of Rpe65 eliminates cone function and remnant minimal visual responses can 
be attributed to rod function due to the presence of 9-cis retinal forming isorhodopsin 
(Seeliger et al. 2001; Fan et al. 2003). R91W mice contain similar amounts of 9-cis 
retinal but, in contrast to Rpe65-/- mice, they also contain 11-cis retinal (Table 4; Figure 
12A, B). The functional tests performed (Figure 13) suggested that the rod system in 
R91W is severely affected, while cone function might be preserved especially in 
younger animals. To test more selectively for the source of visual function in the mutant 
mice we abolished rod function in R91W mice by generating R91W;Rho-/- double 
mutant mice and compared them to single mutant (R91W or Rho-/-) or double mutant 
(Rpe65-/-;Rho-/-) mice. Rho-/- mice lack the rod opsin apoprotein and therefore cannot 
generate a rod derived visual response (Jaissle et al. 2001). Their retina is functionally 
considered a cone-only retina. 
A dark-adapted ERG intensity series of 4 week-old wild-type, single mutant 
(R91W, Rho-/-) and double mutant (R91W;Rho-/- and Rpe65-/-;Rho-/-) mice was 
recorded. All of the mutant mice showed severely depressed ERG responses as 
compared to the wild-type (Figure 15A; compare II, III, IV, V to I; Figure 15B, C). In 
scotopic conditions we found that the retinas of R91W mice and Rho-/- have a 
comparable light sensitivity (Figure 15A; compare II to IV). The oscillatory potentials in 
the leading edge of b-wave and higher b-wave amplitude (Figure 15A; compare II to IV) 
detected probably reflect better inner retinal preservation in R91W mice as compared 
to Rho-/- mice. In R91W;Rho-/- mice only high intensity flashes induced minimal 
responses that were even further reduced in amplitude (Figure 15A; III). In Rpe65-/-
;Rho-/- mice double mutants, as reported by Seeliger et al., no response was detected 
upon stimulation with any intensity of light (Figure 15A; V)(Seeliger et al. 2001). 
To study cone responses, photopic flash intensity series across a 6-log-unit 
intensity range have been recorded in 4 week-old mice of the 5 genotypes described 
above (Figure 16A, B and C). Under the rod-suppressing conditions, comparison 
between the wild-type, R91W and Rho-/- revealed very similar threshold sensitivity 
(Figure 16A; compare I, II, and IV). Additional ablation of rhodopsin in R91W 
(R91W;Rho-/-) resulted in 1.5 log units shift in sensitivity (Figure 16A; compare III to I, II 
and IV). However, the most striking difference was obtained when R91W;Rho-/- mice 
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were directly compared to Rpe65-/-;Rho-/- mice (Figure 16A; compare III to V), where 
the latter mice virtually have no response at all. Collectively, these data prove that 
cones are functional in R91W mice at least at early ages. 
 
 
 
Figure 15 Scotopic ERGs in mice of different Rpe65 status 
Scotopic ERG responses to single-flash stimuli with increasing flash intensities in 4 weeks-old animals of 
different Rpe65 status (wild-type, R91W knock-in or Rpe65 knock-out) in presence or absence of 
functional rhodopsin (Rho). 
A, Loss of sensitivity in R91W animals as compared to 4 week-old wild-type having normal rhodopsin 
(compare I to II). Minimal or no responses were detected in mouse strains on a rhodopsin knock-out 
background (III, IV, V) at low light intensities. Responses at higher intensities demonstrate cone function. 
Only Rpe65-/-;Rho-/- (V) animals had no recordable ERG response 
B, Comparative representation of responses recorded in all tested genotypes at 1 log cd*s/m2 light 
intensity. 
C, The b-wave amplitudes plotted against stimulus intensity in all tested strains indicate reduced amplitude 
of response and sensitivity in all mutant mice. Note the complete lack of response in Rpe65-/-; Rho-/- mice. 
Color coding for mouse strains as in A and B. 
Luminance response function curves (in Fig. A) are representative traces from individual animals. 
Statistical graphs (in Fig. C) represent data obtained from wt;Rho+/+ , R91W;Rho+/+, R91W;Rho-/-(n=3, 
respectively), wt;Rho-/- (n=1) and Rpe65-/-;Rho-/- (n=2). Boxes indicate the 25% and 75% quantile range, 
whiskers indicate the 5% and 95% quantile and the asterisk indicates the median of the data. 
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Figure 16 Cone function is preserved in R91W mice 
Photopic ERG responses to single-flash stimuli with increasing flash intensities in 4 weeks-old animals of 
different Rpe65 status (wild-type, R91W knock-in or Rpe65 knock-out) in presence or absence of 
functional rhodopsin (Rho). 
A, Photopic ERG reflecting an equal sensitivity and similar shape of response between wild-type and 
R91W animals having normal rhodopsin and wild-type Rpe65 on a rhodopsin knock-out background 
(compare I, II and IV). A shift in sensitivity was detected in R91W mice on a rhodopsin knock-out 
background as compared to the above mentioned animals (compare III to I, II, IV). No response was 
recorded in Rpe65-/-;Rho-/-  animals (V). 
B, Comparative representation of responses recorded in all tested genotypes at 3.5 log cd*s/m2 light 
intensity. 
C, The b-wave amplitudes plotted against stimulus intensity in all tested strains indicating reduced 
sensitivity in R91W; Rho-/- animals. Note complete lack of response in Rpe65-/-; Rho-/- mice. Color coding 
for mouse strains as in A and B. 
Luminance response function curves (in Fig. A) are representative traces from individual animals. 
Statistical graphs (in Fig. C) represent data obtained from wt;Rho+/+ , R91W;Rho+/+, R91W;Rho-/-(n=3, 
respectively), wt;Rho-/- (n=1) and Rpe65-/-;Rho-/- (n=2). Boxes indicate the 25% and 75% quantile range, 
whiskers indicate the 5% and 95% quantile and the asterisk indicates the median of the data. 
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3.8 Reduction in cone and rod markers 
 
Previous studies in Rpe65-/- mice have shown that cone markers are reduced 
very early in postnatal development and that RPE65 gene delivery or 9- or 11-cis 
retinal administration prevents the downregulation of cone-specific genes (Znoiko et al. 
2005; Chen et al. 2006b). The authors of the above studies hypothesized that 
chromophore starvation may be responsible for the early cone degeneration.  
We examined the mRNA levels in 4, 8, 12 and 24 week-old R91W and 
corresponding wild-type animals for both cone- and rod-specific markers (Figure 17A 
and B). Red cone opsin (middle wave length; MWL) expression was reduced to 65% 
already at 4 weeks of age (Figure 17A) and by 24 weeks only 47% of wild-type levels 
were expressed. The blue cone opsin (short wave length; SWL) was even more 
suppressed: 23% in 4 weeks and 8% in 24 week-old animals (Figure 17A). Expression 
of cone-specific transducin alpha-subunit (Gnat2) was reduced between 43-26% 
(Figure 17A).  
A reduction of rod-specific markers has not been observed in Rpe65-/- animals up 
to 8 weeks of age (Znoiko et al. 2005). In R91W animals rod opsin mRNA levels were 
reduced down to 41% of wild-type levels already at 4 weeks of age and remained 
reduced up to 24 weeks (Figure 17B). A similar reduction of expression was detected 
for the rod-specific transducin alpha-subunit (Gnat1) (Figure 17B).  
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Figure 17 Reduction in cone and rod RNA markers 
Relative levels of the indicated cone markers (A), and rod markers (B). The expression of markers was 
quantified in retinas of wild-type and R91W mice at 4, 8, 12 and 24 weeks of age by real-time RT-PCR. 
mRNA levels are expressed relative to the level of age matched wild-type control, which was set to 1. RNA 
isolated from 2 independent retinas per time-point and genotype was amplified in triplicates. 
MWL, middle wave length cone opsin; Gnat1, rod-specific transducin alpha-subunit; Gnat2, cone-specific 
transducin alpha-subunit; SWL, short wave length cone opsin. 
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We additionally analyzed the cone markers by immunostaining in 4, 8, 16, 32 and 
40 weeks and quantified the number of cells positive for GNAT2, MWL and SWL-cone 
opsin (Figure 18). As compared to wild-type controls, the 4 week-old R91W animals 
showed reduction in all three tested cone markers. The total Gnat2, MWL and SWL 
positive cells were reduced by 35, 62 and 59%, respectively (data not shown).  
Znoiko at all showed that Rpe65-/- mice exhibited significant cone loss in the 
ventral retina at very early ages (Znoiko et al. 2005). A dorso-ventral gradient of 
expression for MWL and SWL cones has been described in the mouse retina 
(Applebury et al. 2000). In order to analyze the spatial distribution of cones and the 
suspected age-dependent cone loss we quantified the dorso-ventral cone distribution 
in 8, 16, 42, 32 and 40 week-old R91W and compared it to 4 week-old R91W animals 
set as 100% for dorsal, ventral or total expression (Figure 18). The analyzed retinal 
area is described in the methods. By 8 weeks of age the most prominent cone loss 
occurred in the ventral retina where GNAT2 and MWL opsin were reduced by 80% and 
SWL opsin by 70% as compared to their levels in 4 week-old animals (Figure 18). By 
16 weeks of age the ventral retina was cone-free. In the dorsal retina between 4 and 8 
weeks GNAT2 remained stable, but was reduced to 40% by 24 weeks of age. After 32 
weeks of age, GNAT2 positive cells were no longer detectable (Figure 18). A very 
similar pattern in reduction of SWL and MWL opsin containing cones has been 
detected during the ageing in dorsal retina (Figure 18) but to a lesser extent.  
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Figure 18 Geographical distribution and temporal cone cell loss caused by R91W mutation 
Cones were quantified by counting the number of MWL-, SWL- or GNAT2- positive outer segments in 
dorso-ventrally oriented retinal sections cut trough the optic nerve.  
Graphs represent percentages of 4 week-old R91W (set to 100%) for a given cone-marker and region of 
retina (mean ± S.D.). An age-dependent decrease of cone marker labeling was observed that led to an 
almost complete disappearance of cones at 32 weeks of age.  
D, dorsal; V, ventral; T, total (represents sum of dorsal and ventral positive signals) 
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3.9 Degeneration markers 
 
The morphological analysis at 4 weeks of age showed that the OS of R91W were 
slightly disorganized (Figure 14). At this time-point expression of glial fibrillary acidic 
protein (GFAP) mRNA, a marker of retinal gliosis, was upregulated 3 fold (Figure 19). 
Similar GFAP expression-levels were detected at 8 weeks but increased later to a 
maximal 10-fold induction in 24 week-old mutant mice (Figure 19). Caspase-1, another 
marker for retinal degeneration in induced (Grimm et al. 2000) and inherited models  
(Samardzija et al. 2006), was expressed at relative low levels in younger animals 
(Figure 19). However, at 12 and 24 weeks of age, a 3- and 5.5-fold induction was 
detected, respectively. Increased expression of the stress-inducible protein fibroblast 
growth factor 2 (FGF2) has been detected in inherited and induced models for retinal 
degeneration (Gao and Hollyfield 1996; Samardzija et al. 2006). In R91W mice, 
upregulation of FGF2 was detected as early as 4 weeks after birth; and 24 week-old 
animals expressed 10-fold higher FGF2 levels than age-matched wild-types (Figure 
19).  
Comparable low expression of degeneration markers was detected at all time-
points in wild-type and R91W/wt animals (not shown), indicating that one mutant allele 
of Rpe65 is insufficient to trigger pathological changes on retinal morphology. 
 
 
 
 
Figure 19 Retinal degeneration markers are induced in R91W 
Relative mRNA levels of GFAP, Casp-1 and FGF2 in retinas of wild-type and R91W at 4, 8, 12 and 24 
weeks of age as determined by real-time RT-PCR. mRNA levels are expressed relative to age-matched 
wild-type controls, which were set to 1. RNA isolated from 2 independent retinas per time-point and 
genotype was amplified in triplicates (means ± S.D.). 
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4 DISCUSSION  
 
4.1 R91W knock-in mice: close correlation with the human 
phenotype 
 
R91W mice represent the first knock-in animal model of a human blinding 
disease that exactly reproduces the mutation identified in patients. The analyses in the 
present work clearly show that for understanding a particular disease, reproducing a 
mutation is superior to a “simple” knock-out of the gene in question.  
To date, more than 80 mutations have been identified in the Rpe65 gene of 
patients with inherited retinal dystrophies (summarized in (Zernant et al. 2005)). More 
than 60% of them are missense mutations. It has been shown that different mutations 
in Rpe65 are associated with variability in the severity of retinal dystrophy (Hamel et al. 
1999; Lorenz et al. 2000). This may be explained by the different functional 
consequences of the various mutations. However, up to now, all available animal 
models (Rpe65-/- mice; naturally occurring rd12 mice and Swedish Briard dogs) are 
carrying a functionally null allele of the Rpe65 gene. 
Our comparative studies of different mice with selective impairment of rod 
function demonstrated that cones are functional in R91W knock-in mice. This is in 
accordance with the phenotypical characterization of R91W patients that are 
diagnosed with EOSRD. These patients typically have congenital night-blindness but 
retain cone-mediated vision in childhood sufficient to acquire reading in the first decade 
(El Matri et al. 2006). In addition, other reports on patients carrying a mutation in 
Rpe65 demonstrate functional central, that is cone vision early in life (summarized in 
(Paunescu et al. 2005)). As opposed to this relatively mild phenotype, another 
phenotype of the Rpe65-diseases is characterized as legally blind at birth or severely 
visually impaired in infancy. These patients are diagnosed as LCA. 
The observations from R91W patients were not in line with data from Rpe65 
deficient mice. Rpe65-/- mice clearly have no cone function and residual visual function 
in these mice is attributed to desensitized rods supplied with endogenous 9-cis retinal 
as a chromophore (Seeliger et al. 2001; Fan et al. 2003).  
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The work presented here suggests, as hypothesized before, that the level of 
RPE65 impairment (e.g. functional null vs. mutant protein) might control the rate at 
which photoreceptors degenerate (Hamel et al. 1999).  
 
4.2 R91W knock-in mice: metabolic changes induced by the 
mutation 
 
Only recently the enzymatic role of RPE65 as the isomerohydrolase in the visual 
cycle was revealed by several studies in heterologous expression systems (Jin et al. 
2005; Moiseyev et al. 2005; Redmond et al. 2005; Takahashi et al. 2005). In these 
studies a minimal visual cycle has been restored in cell lines different from RPE and 
only cells transfected with RPE65 vectors produced 11-cis retinoids. In parallel, studies 
using the same experimental paradigm were undertaken aiming at understanding the 
pathological changes caused by mutations in Rpe65 shown to be associated with 
human disease (Redmond et al. 2005; Chen et al. 2006a; Takahashi et al. 2006). In 
particular, a study on Rpe65R91W showed that this mutation causes decreased RPE65 
protein levels due to a decreased protein stability and/or protein mislocalisation 
(Takahashi et al. 2006). However, in the same report no isomerohydrolase activity of 
mutant Rpe65R91W protein was detectable.  
To circumvent the limitations of the in vitro heterologous expression systems, 
Chen et al. employed a different strategy: They delivered mutant Rpe65 to the RPE of 
Rpe65 deficient mice by means of an adenoviral vector (Chen et al. 2006b). Using this 
approach, these authors were aiming at RPE65 expression in a more “natural” context. 
Interestingly, this strategy produced results similar to those obtained in vitro. In 
particular, the expression of Rpe65R91W from a viral vector did not result in detectable 
immunostaining of the mutant protein in the RPE and accordingly did not result in a 
gain of retinal function.  
In contrast to R91W expressed in the above-mentioned in vitro or in situ systems, 
R91W expressed as a knock-in gene resulted in: 1) detectable protein expression with 
a correct localization to the RPE and 2) metabolic activity evidenced by generation of 
11-cis retinal. 
R91W knock-in mice as introduced in this work are the most natural system to 
analyze effects of the mutation. The cellular context, temporal expression and genetic 
regulation are as close as possible to the natural situation – with striking consequences 
on the results of the analysis. These data demonstrate that a true assessment of the 
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characteristics of a mutant gene / protein may only be possible, by using the knock-in 
technology. 
 
4.3 R91W knock-in mice: changes in the visual cycle 
 
RPE65 is a protein preferentially and abundantly expressed in the RPE 
microsomal fraction (Hamel et al. 1993a; Seeliger et al. 2001; Hemati et al. 2005). The 
catalytic role of RPE65 as isomerohydrolase in the visual cycle has been established 
recently: In conjunction with LRAT, RPE65 is necessary to synthesize 11-cis retinol 
from all-trans retinyl esters (Jin et al. 2005; Moiseyev et al. 2005; Redmond et al. 
2005). Thus, it catalyzes a key-reaction of the visual cycle, essential to form 11-cis 
isomers out of all-trans isomers. Apparently, RPE65 is the only protein of the RPE able 
to catalyze this reaction as in its absence 11-cis isomers cannot be formed (Redmond 
et al. 1998). 
Like the wild-type protein, the mutant RPE65R91W was expressed exclusively in 
the RPE, but at dramatically reduced levels (5% of wild-type levels). As the RNA levels 
of Rpe65 in wild-type and in R91W knock-in mice were comparable, the reason for the 
reduced amount of mutant RPE65 protein might be at the translational or post-
translational stage. Recently, in agreement with our quantitative data, an in vitro study 
showed that the R91W mutation causes decreased RPE65 protein levels due to a 
decreased protein stability and/or protein mislocalisation of the protein with subsequent 
degradation (Takahashi et al. 2006).  
Comparing Rpe65 knock-out with Rpe65 R91W knock-in mice revealed several 
differences with regard to the visual cycle, the most important one being the limited, but 
measurable ability of R91W knock-in mice to generate 11-cis retinal. The measurable 
amounts of 11-cis retinal indicate that the visual cycle in R91W mutant mice is 
operative, even though at a strongly reduced rate. Rhodopsin amounts are linearly 
correlated with amounts of 11-cis retinal (Wenzel et al. 2005). However, our 
quantitative assessment of rhodopsin showed that the maximal levels of rhodopsin in 
R91W knock-in mice were 40 pmol, which is <10% of wild-type, and did not reach the 
wild-type amounts even after extended rearing for several days in darkness. Thus, 
although the apo-protein opsin is present at levels exceeding 10% of wild-type, only a 
small fraction was equipped with chromophore. The nature of this limitation is currently 
under investigation.  
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Another unexpected limitation of the visual cycle was revealed in experiments 
using a short exposure to bright light to bleach rhodopsin. Normal mice can recover 
their rhodopsin from such a bleach within 1-3 hours (Wenzel et al. 2001). R91W mice 
did not recover rhodopsin to dark-adapted levels within days. This may suggest that in 
addition to the limitation mentioned above, a strong bleach has an additional adverse 
effect on retinal physiology in a way which prevents 11-cis retinal from binding to opsin 
and/or which inhibits the formation of 11-cis retinal. Again, the underlying hindrance of 
the visual cycle remains to be investigated. 
Despite this remnant RPE65 function, the all-trans retinyl ester substrate of the 
isomerohydrolase reaction accumulates in the R91W knock-in mouse comparable to 
RPE65 knock-out mice. Based on the quantification of rhodopsin, the majority of rod 
opsin in R91W mice was in an unliganded state. As 11-cis retinal acts as an inverse 
agonist, its absence will cause an increased spontaneous activity of the opsin 
molecule, leading to a constitutive activation of the phototransduction cascade (Bond et 
al. 1995; Kefalov et al. 1999). It has been hypothesized that due to the presence of 
unliganded opsin retina sends a signal that causes mobilization of retinol from blood 
circulation and its retention in RPE in retinyl ester form (Van Hooser et al. 2002). Thus, 
an insufficient supply with 11-cis retinal, particularly after bleaching, in R91W mice may 
cause the accumulation of similar amounts of retinyl esters as in Rpe65-/- mice.  
Another highly hypothetical possibility is that 11-cis retinal detected in R91W 
mice originates not from the rod but from the proposed cone visual cycle (Mata et al. 
2002). In this alternate pathway the cone pigment is regenerated independently of RPE 
and it is proposed to take place in Müller cells. However, enzymes for proposed 
catalytic steps of the cone pigment regeneration are still not cloned. Hypothetically, a 
cone visual cycle could be less affected by the R91W mutation; or even be fully 
operational. This was evidenced by the light-adapted (cone-specific) ERG having equal 
sensitivity and very similar shape of the response. How would the rods acquire 11-cis 
retinal in this case? 11-cis is covalently bound to rod opsin via a protonated Shiff base 
and this binding is irreversible. The cone opsin /11-cis retinal complex is less stable 
and it has been shown recently in amphibian red cones that the rate of 11-cis retinal 
spontaneous dissociation is approximately 10% (Kefalov et al. 2005). Given that even 
after the prolonged dark adaptation only 40 pmol of rhodopsin is produced or 
approximately 6% of wild-type rhodopsin, hypothetically this 11-cis retinal might be 
“stolen” by rods from neighboring cones due to spontaneous dissociation of 
chromophore. This might explain why rhodopsin regeneration kinetics is inefficient. 
However, this hypothesis is highly unlikely. Even though RPE65 has been detected in 
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cones (Ma et al. 1998; Znoiko et al. 2002) and disputed (Seeliger et al. 2001; Hemati et 
al. 2005) there is no experimental evidence that RPE65 is involved in the cone visual 
cycle. In addition, almost equal amounts of 11-cis retinal were retained up to 40 weeks 
of age, the time when the cones in R91W animals are almost completely lost. 
 
4.4 Cone loss and degeneration 
 
Cone loss was indicated by morphological data, functional studies, RNA 
expression and quantitative analysis of immunohistochemistry. The most affected 
retinal area was the ventral retina that was devoid of cones already at 16 weeks of age. 
It has been shown that the mouse ventral retina is enriched with SWL opsin (Applebury 
et al. 2000) and SWL cones are reduced particularly early in Rpe65-/- mice (Znoiko et 
al. 2005). Thus, qualitatively the geographic cone atrophy was similar between Rpe65 
knock-out and R91W knock-in mice and in both the SWL cones were the most severely 
affected. However, in the knock-out, SWL cone opsin loss is more pronounced: SWL 
RNA is reduced by more than 95% by 4 weeks of age as opposed to less than 80% in 
R91W knock-in mice. For both models, it is not clear why SWL cones are especially 
prone to degeneration.  
Not only do SWL cones appear to be better preserved in the R91W mouse, 
rather all cone-specific markers tested indicate that the cone system in R91W animals 
is less severely affected than in Rpe65 knock-out mice. Recently, Rohrer et al. 
detected cone opsin mislocalization in Rpe65-/- mice (Rohrer et al. 2005), which was 
corrected upon treatment of the mice with 11-cis retinal. Based on this observation, the 
authors hypothesized that cones degenerate because of opsin mislocalization as a 
direct result of 11-cis retinal starvation. This hypothesis might as well explain why 
cones in R91W mice are viable for extended periods of time.  
Similarly, chromophore starvation has been indirectly implicated in rod 
degeneration in Rpe65-/- mice (Redmond et al. 1998; Seeliger et al. 2001), which 
exhibit a slow light-independent degeneration. Rod degeneration can be prevented by 
blocking rod specific G-protein transducin signaling (Gnat1) (Woodruff et al. 2003). 
Rpe65-/-;Gnat1-/- double mutant animals accumulate similar amounts of retinyl esters as 
Rpe65-/- single mutants but nevertheless their rods are protected. Collectively these 
findings indicate that the probable cause of the degeneration in Rpe65-/- animals is 
permanent activation of the transduction cascade by unliganded opsin, and not the 
accumulation of retinyl esters (Woodruff et al. 2003). This concept is reinforced by the 
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observation that systemic supplementation with 11-cis retinal preserves photoreceptor 
structure despite continuing accumulation of retinyl esters. Accordingly, a better 
preservation and slower degeneration of retinal morphology in R91W in comparison to 
Rpe65-/- animals is probably attributable to the presence of 11-cis retinal. However, as 
the levels of 11-cis retinal were not exceeding 10% of wild-type levels during ageing, a 
large fraction of opsin may still have been in the unliganded e.g. activated state. Thus, 
also in R91W mice, the phototransduction cascade may be permanently activated, 
causing retinal degeneration. This possibility will be further investigated by breeding 
R91W mice with transducin knock-out animals, which is currently underway. 
In summary, we generated a new mouse model for retinal dystrophy caused by a 
missense mutation in RPE65. More than 60% of the mutations identified in patients are 
missense mutations. There are striking differences to the knock-out situation, which are 
of importance for the understanding of the pathology and for clinical diagnosis. 
Furthermore, the therapeutic window for gene therapy – the first of which will be carried 
out these days in RPE65 patients – based on the results presented here may differ 
between patients with null- and missense mutations. 
Preclinical trials for gene replacement are underway for the R91W knock-in 
mouse. A thorough analysis of the molecular pathways leading to SWL cone death and 
to rod degeneration will be conducted. 
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ABBREVIATIONS 
11cRDH 11-cis retinol dehydrogenase  
A Absorbance 
ABCR ATP-binding cassette retina 
ACO Apocarotenoid-15,15-oxygenase  
ADRP Autosomal dominant RP 
AMD Age-related macular degeneration  
app. Approximately 
ARRP Autosomal recessive RP 
ATP Adenosine triphosphate 
atRDH All-trans retinol dehydrogenase  
BF Factor B  
bp Base pair(s) 
BSA Bovine serum albumin 
oC Degree Celsius 
C2 Complement component 2 
Ca2+  Calcium 
cAMP Cyclic adenosine monophosphate 
casp-1 Caspase-1 
CD Cone dystrophy 
cd Candela 
cDNA  Complementary deoxyribonucleic acid 
CFH Complement factor H  
cGMP Cyclic guanosine monophosphate  
CNG Cyclic-nucleotide-gated channels  
CRALBP Cellular retinaldehyde binding protein  
CRBP Cellular retinol binding protein 
CRD Cone-rod dystrophy 
CSNB Congenital stationary night blindness 
div. Division 
DNA Deoxynucleic acid 
dNTP Deoxynucleotide 
DT Diphtheria toxin  
dT Deoxytimidine 
EOSRD Early-onset severe retinal dystrophy 
ERG Electroretinogram 
ES Embryonic stem 
EtOH Ethanol 
ABBREVIATIONS 
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FGF2 Fibroblast growth factor 2  
FITC Fluorescein isothiocyanate 
GC Guanylate cyclase 
GCAP Guanylate-cyclase-activating protein 
GCL Ganglion cell layer  
GDP Guanosine diphosphate 
GFAP Glial fibrillary acidic protein  
GMP Guanosine monophosphate 
GNAT1 Guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 1  
GNAT2 Guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 2 
GTP Guanosine triphosphate 
h Hour 
HPLC High performance liquid chromatography 
HR Homologous recombination 
IMH Isomerohydrolase 
INL Inner nuclear layer 
IPL Inner plexiform layer  
IRBP Inter-photoreceptor retinol binding protein 
IS Inner segments 
ISI Inter-stimulus interval  
kb Kilo basepair(s) 
kDa Kilo Dalton 
KI Knock-in 
KO Knock-out  
LCA Leber congenital amaurosis 
loxP Locus of cross-over (x) in P1 
LRAT Lecithin retinol acyl transferase  
m Mili 
mcd*s/m2 Mili candela second per square meter 
MD Macular degeneration 
MerTK C-mer proto-oncogene tyrosine kinase 
min Minute(s) 
mRNA  Messenger ribonucleic acid 
MWL Middle wavelength 
µF  Micro faraday 
µV Micro volt 
 
µg Micrograms 
NADP Oxidized nicotinamide adenine dinucleotide phosphate 
NADPH Reduced nicotinamide adenine dinucleotide phosphate 
ABBREVIATIONS 
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neo Neomycin 
NGS Normal goat serum 
NHS Normal horse serum 
nm Nanometer 
OCT Optical coherence tomography  
OLM Outer limiting membrane  
OMIM Online Mendelian inheritance in man 
ONL Outer nuclear layer  
OPL Outer plexiform layer  
OS Outer segments 
PBS Phosphate buffered saline 
PBST Phosphate buffered saline-triton 
PCR Polymerase chain reaction 
PDE Phosphodiesterase 
PFA Paraformaldehyde 
pmol Picomol 
rd12 Retinal degeneration 12 
RFLP Restriction fragment length polymorphism  
RGR Retinal G-protein-coupled receptor 
Rho Rhodopsin 
RK Rhodopsin kinase  
RNA  Ribonucleic acid 
RP Retinitis pigmentosa 
RPE Retinal pigment epithelium 
RPE65 Retinal pigment epithelium-specific protein 65kDa 
RT Room temperature 
S.D. Standard deviation 
SDS  Sodium dodecyl sulfate 
sec Second 
Stgdt Stargardt 
SWL Short wavelength 
UV Ultraviolet 
V Volt  
wks Weeks 
wt  Wild-type 
XLRS X-linked retinoschisis 
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